Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CR2,Complement receptor type 2,Lifestyle factors,X1050.Time spend outdoors in summer,50256,-0.0273868301308444,0.0258350336606905,-0.0780234961057977,0.0232498358441089,0.289126918738502
CR2,Complement receptor type 2,Lifestyle factors,X1060.Time spent outdoors in winter,48115,-0.0297704098319027,0.0286739416770183,-0.0859713355188587,0.0264305158550532,0.299171982119453
CR2,Complement receptor type 2,Physical activities,X1070.Time spent watching television (TV),51466,0.0595229881655004,0.0262498906288539,0.00807320253294667,0.110972773798054,0.0233660737735033
CR2,Complement receptor type 2,Physical activities,X1080.Time spent using computer,48174,-0.0433483039859145,0.025660443135121,-0.0936427725307516,0.00694616455892268,0.0911775023851823
CR2,Complement receptor type 2,Physical activities,X1090.Time spent driving,43950,-0.0774628307120378,0.0296210013868184,-0.135519993430202,-0.0194056679938738,0.00892836852485239
CR2,Complement receptor type 2,Lifestyle factors,X1160.Sleep duration,52269,-0.00200681682066673,0.0230361769693447,-0.0471577236805823,0.0431440900392489,0.930580159171035
CR2,Complement receptor type 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35640,0.00495893642975688,0.0214309762192473,-0.0370457769599679,0.0469636498194816,0.817018349608814
CR2,Complement receptor type 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35640,-0.0197235383341162,0.0204514897050785,-0.0598084581560701,0.0203613814878377,0.334878618885732
CR2,Complement receptor type 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35640,0.00362912296386064,0.0223045869527162,-0.040087867463463,0.0473461133911843,0.87075386355624
CR2,Complement receptor type 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35640,-0.0507507118718688,0.0224189246291701,-0.0946918041450423,-0.0068096195986953,0.0236229465554087
CR2,Complement receptor type 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35640,-0.0240860156188594,0.0224751978887226,-0.0681374034807556,0.0199653722430369,0.283907995672866
CR2,Complement receptor type 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35640,0.0802357559622385,0.0572120068241284,-0.0318997774130532,0.19237128933753,0.160835447686685
CR2,Complement receptor type 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35640,0.0102051092489273,0.0590648485552739,-0.10556199391941,0.125972212417264,0.862831317078189
CR2,Complement receptor type 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35640,0.018940434625424,0.0384274758073239,-0.0563774179569309,0.0942582872077789,0.622108645690626
CR2,Complement receptor type 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35640,0.0381384291789575,0.0278313175212685,-0.0164109531627288,0.0926878115206439,0.170627822463514
CR2,Complement receptor type 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35640,-0.0201108428528382,0.0182759712998993,-0.0559317466006407,0.0157100608949644,0.27119982664964
CR2,Complement receptor type 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35640,0.04529001832555,0.0275313469416351,-0.00867142168005477,0.0992514583311548,0.100011434264525
CR2,Complement receptor type 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35640,-0.00450718671788105,0.0147736215172631,-0.0334634848917167,0.0244491114559546,0.760312482027307
CR2,Complement receptor type 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35640,0.0287283243638475,0.0193914886721737,-0.00927899343361292,0.0667356421613079,0.13852454483517
CR2,Complement receptor type 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35640,-0.0179469831294973,0.0274630905163695,-0.0717746405415816,0.035880674282587,0.513460737019858
CR2,Complement receptor type 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35640,-0.0117200708900159,0.0259380053610956,-0.0625585613977632,0.0391184196177314,0.651392717097296
CR2,Complement receptor type 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35640,0.0716098014788784,0.0403445321081891,-0.00746548145317215,0.150685084410929,0.0759522015252226
CR2,Complement receptor type 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35640,0.0578667053696255,0.0382171673826181,-0.017038942700306,0.132772353439557,0.130035624812613
CR2,Complement receptor type 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35640,-0.00446023136764251,0.0200721436008219,-0.0438016328252534,0.0348811700899684,0.824157436425812
CR2,Complement receptor type 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35640,-0.00604454574272493,0.0189869736484117,-0.0432590140936118,0.031169922608162,0.750228069503447
CR2,Complement receptor type 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35640,-0.0437967804437842,0.0241463852911318,-0.0911236956144026,0.00353013472683415,0.0697545740872321
CR2,Complement receptor type 2,Health and medical history,X120040.Fatigue severity over the past week,35644,0.0584802762707683,0.0467527293373961,-0.0331550732305279,0.150115625772065,0.211037522259762
CR2,Complement receptor type 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35642,0.0491656249567229,0.0465519255993034,-0.0420761492179118,0.140407399131358,0.29094114739262
CR2,Complement receptor type 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35644,-0.0451011442122285,0.0495142347426248,-0.142149044307773,0.0519467558833162,0.362396718749897
CR2,Complement receptor type 2,Health and medical history,X120098.Mobility problems today,35648,-0.00431889515030167,0.0512912460551011,-0.1048497374183,0.0962119471176964,0.932897361208938
CR2,Complement receptor type 2,Health and medical history,X120099.Self-care problems today,35648,-0.0456982633751751,0.0785314705593976,-0.199619945671594,0.108223418921244,0.560647506854188
CR2,Complement receptor type 2,Health and medical history,X120100.Problems doing usual activities,35648,-0.0401364534856994,0.0496604831996996,-0.137471000557111,0.0571980935857118,0.41899539744355
CR2,Complement receptor type 2,Health and medical history,X120101.Pain or discomfort today,35648,-0.0527582242453111,0.0463469947000288,-0.143598333857368,0.0380818853667453,0.255024535843859
CR2,Complement receptor type 2,Health and medical history,X120102.Anxiety or depression today,35648,-0.0588446145153312,0.0589621927068826,-0.174410512220821,0.0567212831901587,0.318313944232906
CR2,Complement receptor type 2,Health and medical history,X120103.Scale to indicate how health is today,35626,0.0001422295049364,0.00646599534133648,-0.0125311213640831,0.0128155803739559,0.982451400361964
CR2,Complement receptor type 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35623,-0.0640918035088753,0.0603067375372595,-0.182293009081904,0.0541094020641533,0.287929115577492
CR2,Complement receptor type 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35613,-0.148421647232452,0.0633521509583229,-0.272591863110765,-0.024251431354139,0.0191698425453373
CR2,Complement receptor type 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35629,-0.0457612353035793,0.0468699078132013,-0.137626254617454,0.0461037840102953,0.328929868094044
CR2,Complement receptor type 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35628,0.0471351866451382,0.0481107867055966,-0.0471619552978312,0.141432328588108,0.327260309232498
CR2,Complement receptor type 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35639,-0.0278541807820537,0.0694929084075171,-0.164060281260787,0.10835191969668,0.688565591492947
CR2,Complement receptor type 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35619,-0.0859232065384814,0.0680698538214737,-0.21934012002857,0.0474937069516071,0.206893925836511
CR2,Complement receptor type 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35632,-0.00439049127050876,0.0668578667723968,-0.135431910144407,0.126650927603389,0.947643369128615
CR2,Complement receptor type 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35631,-0.0859669332214231,0.092605035451861,-0.267472802707071,0.0955389362642245,0.353277391269817
CR2,Complement receptor type 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35610,-0.108613139996432,0.139875389665023,-0.382768903739877,0.165542623747014,0.437482876266021
CR2,Complement receptor type 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33463,-0.0761697122688138,0.0649729643848031,-0.203516722463028,0.0511772979254003,0.241130304246784
CR2,Complement receptor type 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50464,-0.0265596092573701,0.0575133617186292,-0.139285798225883,0.086166579711143,0.644230236960287
CR2,Complement receptor type 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48667,-0.0858851383333695,0.035100940848015,-0.154682982395479,-0.01708729427126,0.0144216787652366
CR2,Complement receptor type 2,Diet and food preferences,X1289.Cooked vegetable intake,51819,-0.0155861892327046,0.0243342910402713,-0.0632813996716363,0.0321090212062271,0.521852051048627
CR2,Complement receptor type 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51005,-0.0139449142317983,0.0255143901408228,-0.0639531189078109,0.0360632904442144,0.584692864594568
CR2,Complement receptor type 2,Diet and food preferences,X1309.Fresh fruit intake,51735,0.0685898529459869,0.0249540937566994,0.019679829182856,0.117499876709118,0.00598904538406701
CR2,Complement receptor type 2,Diet and food preferences,X1319.Dried fruit intake,50531,0.0408496315883927,0.0250938802965739,-0.00833437379289218,0.0900336369696776,0.103566740106908
CR2,Complement receptor type 2,Health and medical history,X134.Number of self-reported cancers,52478,0.00265730520101497,0.0386892557852802,-0.0731736361381343,0.0784882465401642,0.945242312874553
CR2,Complement receptor type 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52479,0.113794673206299,0.0250766398664854,0.0646444590679879,0.162944887344611,5.71077016879406e-06
CR2,Complement receptor type 2,Health and medical history,"X136.Number of operations, self-reported",52479,0.109046744322749,0.0241283182600513,0.0617552405330482,0.156338248112449,6.23053090876659e-06
CR2,Complement receptor type 2,Health and medical history,X137.Number of treatments or medications taken,52479,0.118955232047075,0.0241402164243664,0.0716404078553169,0.166270056238833,8.37833501114778e-07
CR2,Complement receptor type 2,Diet and food preferences,X1438.Bread intake,51853,0.0173321751696451,0.00376866888151568,0.00994558416187434,0.0247187661774158,4.26782291039892e-06
CR2,Complement receptor type 2,Diet and food preferences,X1458.Cereal intake,51500,0.12312656164124,0.0239671062999043,0.0761510332934277,0.170102089989052,2.81038646220071e-07
CR2,Complement receptor type 2,Diet and food preferences,X1488.Tea intake,51771,0.00468928367299017,0.00365427250135956,-0.00247309042967457,0.0118516577756549,0.199423571256193
CR2,Complement receptor type 2,Diet and food preferences,X1498.Coffee intake,50761,-0.0678941730286992,0.0242072593159707,-0.115340401288002,-0.0204479447693967,0.00504080095340344
CR2,Complement receptor type 2,Diet and food preferences,X1528.Water intake,50588,-0.0104221811765592,0.0241442349705952,-0.0577448817189257,0.0369005193658074,0.665990463621942
CR2,Complement receptor type 2,Lifestyle factors,X1568.Average weekly red wine intake,45068,-0.0718977819840181,0.0278894307861055,-0.126561066324785,-0.0172344976432513,0.0099475373220119
CR2,Complement receptor type 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45065,-0.0558753725183859,0.0285711044854594,-0.111874737309886,0.000123992273114486,0.0505227149361936
CR2,Complement receptor type 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,45115,-0.11460402409108,0.0322307029191898,-0.177776201812692,-0.0514318463694679,0.000378008892056358
CR2,Complement receptor type 2,Lifestyle factors,X1598.Average weekly spirits intake,45050,-0.0629528959392392,0.0300210511067596,-0.121794156108488,-0.00411163576999043,0.0360130558042657
CR2,Complement receptor type 2,Lifestyle factors,X1608.Average weekly fortified wine intake,45096,0.0168292315693478,0.0453878805123612,-0.0721310142348802,0.105789477373576,0.710801197649886
CR2,Complement receptor type 2,Lifestyle factors,X1737.Childhood sunburn occasions,46119,-0.0472745995664345,0.0292083281844161,-0.10452292280789,0.00997372367502106,0.105566735749112
CR2,Complement receptor type 2,Health and medical history,X1807.Father's age at death,50329,0.00682493701618286,0.00352812353669032,-9.01851157301759e-05,0.0137400591480959,0.0530726010027724
CR2,Complement receptor type 2,Health and medical history,X1845.Mother's age,32618,-0.0232929779138566,0.0162976867992046,-0.0552364440402976,0.0086504882125844,0.153032270901199
CR2,Complement receptor type 2,Health and medical history,X1873.Number of full brothers,52059,-0.0397572660693677,0.0231098462569053,-0.085052564732902,0.00553803259416667,0.0853804678881206
CR2,Complement receptor type 2,Health and medical history,X1883.Number of full sisters,52065,-0.0144088523569273,0.0231960104307821,-0.0598730328012603,0.0310553280874056,0.534488675746475
CR2,Complement receptor type 2,Physical measures,X20015.Sitting height,52307,0.0278389078268126,0.00471055615465611,0.0186062177636866,0.0370715978899385,3.47120094633167e-09
CR2,Complement receptor type 2,Cognitive function,X20016.Fluid intelligence score,36785,-0.0476590540913107,0.0373712130671267,-0.120906631702879,0.0255885235202576,0.202246464526391
CR2,Complement receptor type 2,Cognitive function,X20018.Prospective memory result,37141,0.0373567059993249,0.0459041845497602,-0.0526154957182051,0.127328907716855,0.415785410539586
CR2,Complement receptor type 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36663,0.016399597183126,0.00643487864578404,0.00378723503738927,0.0290119593288627,0.0108370755672281
CR2,Complement receptor type 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36645,0.0152107043873354,0.00648089699420939,0.002508146278685,0.0279132624959858,0.0189509862105482
CR2,Complement receptor type 2,Cognitive function,X20023.Mean time to correctly identify matches,52168,0.00295529051782178,0.0038521925161276,-0.00459500681378831,0.0105055878494319,0.442987715841157
CR2,Complement receptor type 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49025,0.00444492286831362,0.00802934617967085,-0.0112925956438412,0.0201824413804685,0.579869368430846
CR2,Complement receptor type 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48569,-0.0135891400394038,0.0171014596553644,-0.047108000963918,0.0199297208851103,0.426845056617346
CR2,Complement receptor type 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48532,-0.0116605286680343,0.0228582030367989,-0.0564626066201602,0.0331415492840915,0.60997008630362
CR2,Complement receptor type 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48540,-0.0168282000347753,0.0218741857703206,-0.0597016041446038,0.0260452040750531,0.441714077085343
CR2,Complement receptor type 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48563,0.000229535896301904,0.0151499873228336,-0.0294644392564519,0.0299235110490557,0.987911951787089
CR2,Complement receptor type 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48742,0.0204557087883072,0.0100933716081175,0.000672700436396865,0.0402387171402174,0.0427119981071859
CR2,Complement receptor type 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48683,-0.00751935591577146,0.012345261025958,-0.0317160675266491,0.0166773556951061,0.542472911928286
CR2,Complement receptor type 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48584,-0.0121065303774855,0.0160009583608435,-0.0434684087647388,0.0192553480097679,0.449291045619913
CR2,Complement receptor type 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48737,-0.0117641655534384,0.0108928063486691,-0.0331140659968298,0.00958573488995304,0.280158177762001
CR2,Complement receptor type 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48728,0.011326209095443,0.0101156850324454,-0.00850053356814997,0.0311529517590359,0.262869021836884
CR2,Complement receptor type 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48606,0.0337351137829175,0.014425034355896,0.00546204644536121,0.0620081811204737,0.0193636221951926
CR2,Complement receptor type 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50145,0.0211592985799876,0.00873570593927567,0.00403731493900733,0.038281282220968,0.015436880961679
CR2,Complement receptor type 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49981,-0.0148305958858169,0.0113870916095149,-0.0371492954404661,0.00748810366883226,0.192792678689023
CR2,Complement receptor type 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49888,-0.00276478146225847,0.0253595867525632,-0.0524695714972822,0.0469400085727653,0.9131852035709
CR2,Complement receptor type 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49914,0.0153192524580726,0.0158419755264235,-0.0157310195737175,0.0463695244898627,0.333553359877997
CR2,Complement receptor type 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50077,-0.00800918119056459,0.00958161877404826,-0.0267891539876992,0.01077079160657,0.40322624236337
CR2,Complement receptor type 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49935,0.0129703318269206,0.0183850595330299,-0.0230643848578179,0.0490050485116592,0.480518142457003
CR2,Complement receptor type 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49922,-0.0241680535916369,0.0155052089828802,-0.054558263198082,0.00622215601480824,0.11908138045246
CR2,Complement receptor type 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49926,-0.015635835109086,0.0136697155516913,-0.0424284775904009,0.0111568073722289,0.252707219752179
CR2,Complement receptor type 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49972,-0.00513674826636751,0.0152747276730945,-0.0350752145056328,0.0248017179728978,0.736655087627594
CR2,Complement receptor type 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50121,0.0289702546843953,0.00849502841589173,0.0123199989892476,0.0456205103795431,0.000650235257231289
CR2,Complement receptor type 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49983,0.00764540268262004,0.0130328244736189,-0.017898933285673,0.0331897386509131,0.557460823003557
CR2,Complement receptor type 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46297,0.0017762863587849,0.0110676651665808,-0.0199163373677135,0.0234689100852833,0.872494376496933
CR2,Complement receptor type 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46120,-0.0174751893633607,0.038515269094874,-0.0929651167893136,0.0580147380625923,0.650035412040787
CR2,Complement receptor type 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46111,-0.00329170126890504,0.0410578879055074,-0.0837651615636996,0.0771817590258895,0.936101247177908
CR2,Complement receptor type 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46143,-0.0163376433388139,0.0169056588210491,-0.0494727346280702,0.0167974479504425,0.33385741933235
CR2,Complement receptor type 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46136,0.00992031693948325,0.0229362359313943,-0.0350347054860495,0.054875339365016,0.665371046608584
CR2,Complement receptor type 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46170,-0.018637472896823,0.0184795908224598,-0.0548574709088442,0.0175825251151982,0.313207946508379
CR2,Complement receptor type 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46135,-0.0503531479270685,0.0205449035831606,-0.0906211589500634,-0.0100851369040736,0.014260674081563
CR2,Complement receptor type 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46129,0.00514801947720371,0.0206657242201134,-0.0353567999942185,0.0456528389486259,0.803279429660637
CR2,Complement receptor type 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46149,-0.0159410772276056,0.0169882620890224,-0.0492380709220895,0.0173559164668783,0.348073659889791
CR2,Complement receptor type 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46164,-0.00385262742574464,0.0200438585832868,-0.0431385902489868,0.0354333353974975,0.847580115832096
CR2,Complement receptor type 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46339,0.0182007063130775,0.00930968747085605,-4.62811298003601e-05,0.0364476937559554,0.0505959061022726
CR2,Complement receptor type 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46231,0.0259100914598802,0.0128214753760877,0.000779999722748267,0.0510401831970122,0.0433124170538023
CR2,Complement receptor type 2,Mental health,X20127.Neuroticism score,47491,0.00640159458342686,0.0242182045133744,-0.041066086262787,0.0538692754296407,0.791528733055288
CR2,Complement receptor type 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36785,0.0115759532170815,0.037805252054663,-0.062522340810058,0.085674247244221,0.759461083211772
CR2,Complement receptor type 2,Lifestyle factors,X20161.Pack years of smoking,37057,0.0054492879510721,0.00628517362750032,-0.00686965235882853,0.0177682282609727,0.385964765172196
CR2,Complement receptor type 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,37057,0.00491485806643296,0.00649441547882827,-0.00781419627207045,0.0176439124049364,0.4492030272548
CR2,Complement receptor type 2,Cognitive function,X20191.Fluid intelligence score,34371,-0.076631734952304,0.0474283920671447,-0.169591383403908,0.0163279134992995,0.106212595601631
CR2,Complement receptor type 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34372,-0.163730834619286,0.0483069360674626,-0.258412429311513,-0.0690492399270596,0.00070573945793438
CR2,Complement receptor type 2,Cognitive function,X20240.Maximum digits remembered correctly,33719,-0.0537458733575683,0.0515328042209881,-0.154750169630705,0.0472584229155684,0.297029644655394
CR2,Complement receptor type 2,Physical measures,X20255.Spirometry QC measure,46385,0.039058886432921,0.0309783747025006,-0.0216587279839802,0.0997765008498222,0.207382299964228
CR2,Complement receptor type 2,Eye measures,X20261.avMSE,34365,0.00573005688417041,0.00715835257813304,-0.00830031416897035,0.0197604279373112,0.42347447105531
CR2,Complement receptor type 2,Eye measures,X20262.Myopia diagnosis,34365,-0.0418294874626898,0.0599358099224976,-0.159303674910785,0.0756446999854055,0.485268138923405
CR2,Complement receptor type 2,NMR metabolomics,X20280.Glucose-lactate,42656,0.0150433790214965,0.00471473302345382,0.00580250229552704,0.024284255747466,0.0014224581503649
CR2,Complement receptor type 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42683,0.012657890330938,0.0048339913618905,0.00318326726163267,0.0221325134002434,0.00884115141010535
CR2,Complement receptor type 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36475,-0.0967203578529448,0.0299082219069609,-0.155340472790588,-0.0381002429153015,0.00122654608293965
CR2,Complement receptor type 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36475,-0.0269182272464039,0.0561577544386218,-0.136987425946103,0.0831509714532949,0.63171662245909
CR2,Complement receptor type 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36476,0.0380209278565863,0.0951710863775642,-0.148514401443439,0.224556257156612,0.689535929685391
CR2,Complement receptor type 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36476,-0.0469295917258061,0.0273980251423527,-0.100629721004817,0.00677053755320531,0.0867767672198727
CR2,Complement receptor type 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36476,-0.00925534268293293,0.0576172717908838,-0.122185195393065,0.103674510027199,0.872385448846367
CR2,Complement receptor type 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36479,-0.113002204826255,0.0733282853382614,-0.256725644089247,0.0307212344367375,0.12334920976002
CR2,Complement receptor type 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36479,-0.00932406709539169,0.0451084098506752,-0.0977365504027152,0.0790884162119318,0.836247184993726
CR2,Complement receptor type 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36479,-0.0604331152751755,0.0541030775475505,-0.166475147268374,0.0456089167180235,0.264031339415965
CR2,Complement receptor type 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36479,0.0598224468114153,0.0840336755108919,-0.104883557189933,0.224528450812764,0.476557801765635
CR2,Complement receptor type 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36479,0.046320853306541,0.0966272711550914,-0.143068598157438,0.23571030477052,0.631685122652613
CR2,Complement receptor type 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36479,0.016626948330386,0.0600595737314477,-0.101089816183252,0.134343712844024,0.78191010447616
CR2,Complement receptor type 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36479,-0.10811970656979,0.0998586235745612,-0.30384260877593,0.0876031956363503,0.278965101711646
CR2,Complement receptor type 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36479,-0.097135129987408,0.0701899797244406,-0.234707490247312,0.0404372302724956,0.166434889220773
CR2,Complement receptor type 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36478,-0.0709599843672921,0.0965993707725879,-0.260294751081564,0.11837478234698,0.462618851727639
CR2,Complement receptor type 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36478,-0.105420550030864,0.0371128072829837,-0.178161652305512,-0.032679447756216,0.00451616326901419
CR2,Complement receptor type 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36478,-0.0938638624568654,0.0690679831015302,-0.229237109335865,0.0415093844221338,0.174186493196559
CR2,Complement receptor type 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36480,0.13201350287024,0.120305425662317,-0.103785131427901,0.367812137168382,0.272537964808957
CR2,Complement receptor type 2,Diet and food preferences,X20600.Liking for adding salt to foods,36292,-0.122375739081545,0.0398797572253861,-0.200540063243301,-0.044211414919788,0.00215863600978
CR2,Complement receptor type 2,Diet and food preferences,X20601.Liking for aniseed,36292,-0.017478416502449,0.040037395479041,-0.0959517116413694,0.0609948786364713,0.662449367967355
CR2,Complement receptor type 2,Diet and food preferences,X20602.Liking for apple juice,36292,0.0110524568403469,0.0399805548202851,-0.0673094306074119,0.0894143442881056,0.782213735191541
CR2,Complement receptor type 2,Diet and food preferences,X20603.Liking for apples,36292,0.0682163474756298,0.0413270528749983,-0.012784676159367,0.149217371110627,0.0988551137784178
CR2,Complement receptor type 2,Diet and food preferences,X20604.Liking for asparagus,36292,0.000253962258165948,0.0408751125770462,-0.0798612583928446,0.0803691829091764,0.995042848757715
CR2,Complement receptor type 2,Diet and food preferences,X20605.Liking for aubergine,36292,-0.0197463006946809,0.0402155631630574,-0.0985688044942734,0.0590762031049117,0.623433571354597
CR2,Complement receptor type 2,Diet and food preferences,X20606.Liking for avocados,36292,-0.0614616716789184,0.0403111125869344,-0.14047145234931,0.017548108991473,0.127382770086206
CR2,Complement receptor type 2,Diet and food preferences,X20607.Liking for bacon,36292,-0.0641034745242094,0.0410613832369631,-0.144583785668657,0.0163768366202382,0.118530151156029
CR2,Complement receptor type 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36292,-0.0383173539900434,0.040752267785476,-0.118191798849576,0.0415570908694895,0.347120946375596
CR2,Complement receptor type 2,Diet and food preferences,X20609.Liking for bananas,36292,0.0733764707595291,0.0417962532462002,-0.00854418560302334,0.155297127122081,0.0792041343757696
CR2,Complement receptor type 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36292,-0.0493907832633688,0.0405844245012241,-0.128936255285768,0.0301546887590304,0.223649054024935
CR2,Complement receptor type 2,Diet and food preferences,X20611.Liking for beef steak,36292,-0.051220012220614,0.0410587289927762,-0.131695121046455,0.0292550966052273,0.212262141629128
CR2,Complement receptor type 2,Diet and food preferences,X20612.Liking for beetroot,36292,0.0136072722289279,0.0407714369076234,-0.0663047441100141,0.0935192885678698,0.738581693993358
CR2,Complement receptor type 2,Diet and food preferences,X20613.Liking for bell pepper,36292,-0.0185773513155131,0.0402512055790781,-0.0974697142505062,0.0603150116194799,0.644428779212023
CR2,Complement receptor type 2,Diet and food preferences,X20614.Liking for bicycling,36292,-0.0527900159805596,0.0399573988171802,-0.131106517662233,0.0255264857011135,0.186491504465307
CR2,Complement receptor type 2,Diet and food preferences,X20615.Liking for biscuits,36292,-0.0185765516513049,0.0402654286044877,-0.0974967917161008,0.0603436884134909,0.644559959492757
CR2,Complement receptor type 2,Diet and food preferences,X20616.Liking for bitter foods,36292,-0.0350245554027402,0.0405619083713108,-0.114525895810509,0.0444767850050289,0.387900672895343
CR2,Complement receptor type 2,Diet and food preferences,X20617.Liking for bitter or ale,36292,-0.130097553840044,0.041348802839892,-0.211141207406232,-0.0490539002738551,0.00166009978688333
CR2,Complement receptor type 2,Diet and food preferences,X20618.Liking for black olives,36292,-0.086013237478296,0.0403277398902556,-0.165055607663197,-0.00697086729339512,0.032970844503525
CR2,Complement receptor type 2,Diet and food preferences,X20619.Liking for black pepper,36292,0.015267177585249,0.0407155093780174,-0.0645352207956652,0.0950695759661631,0.707692478677747
CR2,Complement receptor type 2,Diet and food preferences,X20620.Liking for blue cheese,36292,-0.0256526045517913,0.0406846259275105,-0.105394471369712,0.0540892622661293,0.528372588889582
CR2,Complement receptor type 2,Diet and food preferences,X20621.Liking for bolognese sauce,36292,-0.0632181231488273,0.0407060208347534,-0.143001923984944,0.0165656776872894,0.120457957228697
CR2,Complement receptor type 2,Diet and food preferences,X20622.Liking for broad beans,36292,0.0127034699922593,0.0403237080403601,-0.0663309977668465,0.0917379377513652,0.752742645669218
CR2,Complement receptor type 2,Diet and food preferences,X20623.Liking for broccoli,36292,-0.0197406385926403,0.0413649404619944,-0.100815921898149,0.0613346447128686,0.633212235458156
CR2,Complement receptor type 2,Diet and food preferences,X20624.Liking for brown rice,36292,-0.00274910183220984,0.0406937101184611,-0.0825087736643935,0.0770105699999738,0.946141035336086
CR2,Complement receptor type 2,Diet and food preferences,X20625.Liking for brussel sprouts,36292,0.0330430667715381,0.0405721177090696,-0.0464782839382383,0.112564417481314,0.415427187706553
CR2,Complement receptor type 2,Diet and food preferences,X20626.Liking for burgers (meat),36292,-0.0846759654927548,0.0406146665757253,-0.164280711981176,-0.00507121900433317,0.0371175472821936
CR2,Complement receptor type 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36292,-0.0370428848400053,0.0401948095616443,-0.115824711580828,0.0417389419008175,0.356777079946112
CR2,Complement receptor type 2,Diet and food preferences,X20628.Liking for butter on bread,36292,0.0479293975972381,0.0406792358472156,-0.0318019046633044,0.127660699857781,0.23874543914078
CR2,Complement receptor type 2,Diet and food preferences,X20629.Liking for butternut squash,36292,-0.02947193845235,0.0407442381278177,-0.109330645182873,0.0503867682781726,0.469494870490663
CR2,Complement receptor type 2,Diet and food preferences,X20630.Liking for cabbage,36292,0.0604300306135954,0.0407858198367508,-0.0195101762664362,0.140370237493627,0.138479717397343
CR2,Complement receptor type 2,Diet and food preferences,X20631.Liking for cake,36292,0.02468203422167,0.0405820484509148,-0.054858780742123,0.104222849185463,0.543073790837662
CR2,Complement receptor type 2,Diet and food preferences,X20632.Liking for cake icing,36292,-0.00263412007827822,0.0399003248102016,-0.0808387567062733,0.0755705165497168,0.947365746788742
CR2,Complement receptor type 2,Diet and food preferences,X20633.Liking for capers,36292,-0.046132498299445,0.040349480613414,-0.125217480301736,0.0329524837028464,0.252943023763062
CR2,Complement receptor type 2,Diet and food preferences,X20634.Liking for cauliflower,36292,-0.0123681299893051,0.0411513411669773,-0.0930247586765805,0.0682884986979704,0.763764727668351
CR2,Complement receptor type 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36292,0.0112705481922056,0.0398492397471396,-0.0668339617121881,0.0893750580965992,0.777315650286583
CR2,Complement receptor type 2,Diet and food preferences,X20636.Liking for cheesecake,36292,-0.00757178040838527,0.0401280842973701,-0.0862228256312307,0.0710792648144602,0.850340953002926
CR2,Complement receptor type 2,Diet and food preferences,X20637.Liking for cherries,36292,0.0332200469641112,0.0429566608514841,-0.0509750083047976,0.11741510223302,0.439347761547058
CR2,Complement receptor type 2,Diet and food preferences,X20638.Liking for chicken,36292,0.0224941078097032,0.0426914418510626,-0.0611811182183795,0.106169333837786,0.598279730335939
CR2,Complement receptor type 2,Diet and food preferences,X20639.Liking for chilli pepper,36292,-0.0231004092430728,0.0398146964270465,-0.101137214240084,0.0549363957539385,0.561799508799275
CR2,Complement receptor type 2,Diet and food preferences,X20640.Liking for chips or french fries,36292,-0.00471645553088183,0.0400052384188319,-0.0831267228317924,0.0736938117700287,0.906153443565616
CR2,Complement receptor type 2,Diet and food preferences,X20641.Liking for cigarette smoking,36292,-0.0843773792943847,0.0691259178957163,-0.219864178369989,0.0511094197812193,0.22226558987292
CR2,Complement receptor type 2,Diet and food preferences,X20642.Liking for cod,36292,0.0247204983094328,0.0416489552118514,-0.0569114539057961,0.106352450524662,0.552835908474873
CR2,Complement receptor type 2,Diet and food preferences,X20643.Liking for coffee with sugar,36292,-0.0503193552357508,0.043920591118488,-0.136403713827987,0.0357650033564857,0.251962369532854
CR2,Complement receptor type 2,Diet and food preferences,X20644.Liking for coffee without sugar,36292,-0.0726844332165188,0.0409909608182507,-0.15302671642029,0.00765784998725264,0.0762414844475411
CR2,Complement receptor type 2,Diet and food preferences,X20645.Liking for coriander,36292,-0.0601033386073802,0.0403412397759451,-0.139172168568233,0.0189654913534722,0.136302024472492
CR2,Complement receptor type 2,Diet and food preferences,X20646.Liking for corn flakes,36292,0.0251118758911207,0.0398587445922176,-0.0530112635096258,0.103235015291867,0.528700662061388
CR2,Complement receptor type 2,Diet and food preferences,X20647.Liking for cream,36292,0.0238752095339936,0.0405636790705487,-0.0556296014442817,0.103380020512269,0.556157847283806
CR2,Complement receptor type 2,Diet and food preferences,X20648.Liking for croissant,36292,-0.048395718130332,0.0398617430999085,-0.126524734606153,0.0297332983454887,0.224754046892427
CR2,Complement receptor type 2,Diet and food preferences,X20649.Liking for cucumber,36292,0.0619436788953795,0.0408970643174214,-0.0182145671667664,0.142101924957525,0.129912210495858
CR2,Complement receptor type 2,Diet and food preferences,X20650.Liking for curry,36292,-0.0596264097541086,0.0402266745574945,-0.138470691886798,0.0192178723785807,0.138315450439242
CR2,Complement receptor type 2,Diet and food preferences,X20651.Liking for dairy products,36292,0.0560427027630039,0.0412488477765778,-0.0248050388790885,0.136890444405096,0.174301092108357
CR2,Complement receptor type 2,Diet and food preferences,X20652.Liking for dark chocolate,36292,-0.00270458690866188,0.0407361498948123,-0.082547440702494,0.0771382668851703,0.947066977379478
CR2,Complement receptor type 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36292,0.0287820596879907,0.0418565970367896,-0.053256870504117,0.110820989880098,0.491705179986324
CR2,Complement receptor type 2,Diet and food preferences,X20654.Liking for dried fruit,36292,0.0328808832958947,0.0403731495935639,-0.0462504899074905,0.11201225649928,0.415429149025782
CR2,Complement receptor type 2,Diet and food preferences,X20655.Liking for eggs,36292,0.00328322741147065,0.0417060957406896,-0.078460720240281,0.0850271750632223,0.937255202625018
CR2,Complement receptor type 2,Diet and food preferences,X20656.Liking for exercising alone,36292,-0.0542021777670469,0.0401117476687186,-0.132821203197735,0.0244168476636416,0.176649073767485
CR2,Complement receptor type 2,Diet and food preferences,X20657.Liking for exercising with others,36292,0.0459174133771947,0.0396652200564661,-0.0318264179334789,0.123661244687868,0.247056484786165
CR2,Complement receptor type 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36292,-0.0704165348754502,0.0406801807794364,-0.150149689203146,0.0093166194522452,0.0834990384313279
CR2,Complement receptor type 2,Diet and food preferences,X20659.Liking for fatty foods,36292,-0.066728602670862,0.040045275657607,-0.145217342959772,0.0117601376180477,0.0956920899986325
CR2,Complement receptor type 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36292,-0.022286370832039,0.043288290124761,-0.107131419476571,0.0625586778124926,0.606683666495949
CR2,Complement receptor type 2,Diet and food preferences,X20661.Liking for fried chicken,36292,-0.043208214952728,0.0401365002038087,-0.121875755352193,0.035459325446737,0.281726163950225
CR2,Complement receptor type 2,Diet and food preferences,X20662.Liking for fried or battered fish,36292,-0.0159332230100402,0.0402618087058583,-0.0948463680735224,0.062979922053442,0.692308480899664
CR2,Complement receptor type 2,Diet and food preferences,X20663.Liking for fruit,36292,0.0891347856903478,0.0462452878214126,-0.0015059784396209,0.179775549820317,0.0539653522436743
CR2,Complement receptor type 2,Diet and food preferences,X20664.Liking for garlic,36292,-0.0367983187720014,0.0406389691252728,-0.116450698257536,0.0428540607135334,0.365234822373228
CR2,Complement receptor type 2,Diet and food preferences,X20665.Liking for gherkins,36292,-0.0728325834189975,0.0401285578474143,-0.151484556799929,0.0058193899619345,0.0695690192811006
CR2,Complement receptor type 2,Diet and food preferences,X20666.Liking for globe artichoke,36292,-0.060296441352311,0.0402129377273262,-0.13911379929787,0.0185209165932483,0.133806928641135
CR2,Complement receptor type 2,Diet and food preferences,X20667.Liking for goat's cheese,36292,-0.0246523379185557,0.0397721195504159,-0.102605692237371,0.0533010164002594,0.535383262762603
CR2,Complement receptor type 2,Diet and food preferences,X20668.Liking for going to a cafe,36292,-0.000525462428579523,0.0405252125983327,-0.0799548791213116,0.0789039542641525,0.989655037001057
CR2,Complement receptor type 2,Diet and food preferences,X20669.Liking for going to the gym,36292,-0.00761952226906926,0.0398796607236295,-0.0857836572873831,0.0705446127492446,0.848481811884226
CR2,Complement receptor type 2,Diet and food preferences,X20670.Liking for going to the pub,36292,-0.168555561315866,0.0403937395744767,-0.24772729088184,-0.0893838317498913,3.0445535018068e-05
CR2,Complement receptor type 2,Diet and food preferences,X20671.Liking for grapefruit,36292,0.00314537287796842,0.0407279095465778,-0.0766813298333241,0.0829720755892609,0.938443606996322
CR2,Complement receptor type 2,Diet and food preferences,X20672.Liking for green olives,36292,-0.0482375652888752,0.04021199024959,-0.127053066178072,0.0305779356003213,0.230341950707444
CR2,Complement receptor type 2,Diet and food preferences,X20673.Liking for haddock,36292,-0.0359785920214695,0.0413781578005216,-0.117079781310492,0.0451225972675529,0.384599396640121
CR2,Complement receptor type 2,Diet and food preferences,X20674.Liking for ham,36292,-0.0361449486690896,0.0410795155755139,-0.116660799197097,0.0443709018589176,0.37895540547269
CR2,Complement receptor type 2,Diet and food preferences,X20675.Liking for hard cheese,36292,-0.0139831730453337,0.0415002612486707,-0.0953236850927281,0.0673573390020608,0.736170742673592
CR2,Complement receptor type 2,Diet and food preferences,X20676.Liking for herring,36292,-0.0566919511787042,0.0401526661465944,-0.135391176826029,0.0220072744686207,0.158020352482314
CR2,Complement receptor type 2,Diet and food preferences,X20677.Liking for honey,36292,0.0588626065991573,0.0407767281594547,-0.021059780593374,0.138784993791689,0.148914199442214
CR2,Complement receptor type 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36292,-0.0132944668018207,0.0398729065036453,-0.0914453635489655,0.064856429945324,0.738826328215205
CR2,Complement receptor type 2,Diet and food preferences,X20679.Liking for ice cream,36292,-0.00760690655364848,0.0403376269419776,-0.0866686553599247,0.0714548422526277,0.850426690969117
CR2,Complement receptor type 2,Diet and food preferences,X20680.Liking for jam,36292,0.000258710217020204,0.0400612214533227,-0.0782612838314923,0.0787787042655327,0.994847581626469
CR2,Complement receptor type 2,Diet and food preferences,X20681.Liking for kiwi fruit,36292,0.0417527100748814,0.0402770898646585,-0.0371903860598493,0.120695806209612,0.299940554842539
CR2,Complement receptor type 2,Diet and food preferences,X20682.Liking for lager,36292,-0.0918988400107239,0.0405627029414724,-0.17140173777601,-0.0123959422454381,0.0235059496556758
CR2,Complement receptor type 2,Diet and food preferences,X20683.Liking for lamb,36292,-0.0979486734798826,0.0411849020878196,-0.178671081572009,-0.0172262653877562,0.0174205922487069
CR2,Complement receptor type 2,Diet and food preferences,X20684.Liking for lemons,36292,0.00775426846918823,0.0405869545252943,-0.0717961624003886,0.0873046993387651,0.848489366458278
CR2,Complement receptor type 2,Diet and food preferences,X20685.Liking for lentils or beans,36292,0.0981660551733161,0.0405604519120772,0.0186675694256447,0.177664540920987,0.0155352123484895
CR2,Complement receptor type 2,Diet and food preferences,X20686.Liking for liver,36292,-0.0831137187729232,0.040569089573383,-0.162629134336754,-0.00359830320909246,0.0405286243407388
CR2,Complement receptor type 2,Diet and food preferences,X20687.Liking for mackerel,36292,-0.0748311021286855,0.0401125868505668,-0.153451772355796,0.00378956809842536,0.0621488874412571
CR2,Complement receptor type 2,Diet and food preferences,X20688.Liking for marzipan,36292,-0.0356226184631644,0.0400982164807953,-0.114215122765523,0.0429698858391944,0.374364310204652
CR2,Complement receptor type 2,Diet and food preferences,X20689.Liking for mayonnaise,36292,-0.0522140970362608,0.0404054256428047,-0.131408731296158,0.0269805372236365,0.196311111541408
CR2,Complement receptor type 2,Diet and food preferences,X20690.Liking for melon,36292,0.0722437292007502,0.041795118183859,-0.00967470243961351,0.154162160841114,0.0839384457886236
CR2,Complement receptor type 2,Diet and food preferences,X20691.Liking for milk chocolate,36292,0.0384839766771936,0.0398836295124298,-0.0396879371671689,0.116655890521556,0.334624518056556
CR2,Complement receptor type 2,Diet and food preferences,X20692.Liking for mushrooms,36292,0.0177818915112846,0.0412179075113103,-0.0630052072108836,0.0985689902334529,0.666182093002235
CR2,Complement receptor type 2,Diet and food preferences,X20694.Liking for orange juice,36292,0.0193065461947164,0.0401727166421273,-0.0594319784238532,0.0980450708132859,0.630823810763982
CR2,Complement receptor type 2,Diet and food preferences,X20695.Liking for oranges,36292,0.0296174620659538,0.0412914931081761,-0.0513138644260714,0.110548788557979,0.47322647385974
CR2,Complement receptor type 2,Diet and food preferences,X20696.Liking for pasta,36292,-0.0335729105861964,0.0405536520560769,-0.113058068616107,0.0459122474437143,0.407775365300076
CR2,Complement receptor type 2,Diet and food preferences,X20697.Liking for pears,36292,0.023793930679627,0.0412201051506489,-0.0569974754156448,0.104585336774899,0.563795060905121
CR2,Complement receptor type 2,Diet and food preferences,X20698.Liking for pizza,36292,-0.00424878950305175,0.0402378457678998,-0.0831149672081353,0.0746173882020318,0.915909160580021
CR2,Complement receptor type 2,Diet and food preferences,X20699.Liking for plain yogurt,36292,0.0562447664955626,0.0403211571423722,-0.022784701503487,0.135274234494612,0.163083832652349
CR2,Complement receptor type 2,Diet and food preferences,X20700.Liking for plums,36292,0.0519999148533897,0.0411718774977312,-0.0286969650421634,0.132696794748943,0.206632171825384
CR2,Complement receptor type 2,Diet and food preferences,X20701.Liking for pollock,36292,-0.0417001824914363,0.0398322266447064,-0.119771346715061,0.0363709817321882,0.295183427959039
CR2,Complement receptor type 2,Diet and food preferences,X20702.Liking for pork chop,36292,-0.0360517273694649,0.0405903824489769,-0.11560887696946,0.0435054222305298,0.374471929845537
CR2,Complement receptor type 2,Diet and food preferences,X20703.Liking for porridge,36292,0.0826237352219412,0.0413226644832434,0.0016313128347842,0.163616157609098,0.0455948181569697
CR2,Complement receptor type 2,Diet and food preferences,X20704.Liking for potato crisps,36292,0.0190740581618248,0.0401284343482383,-0.0595776731607222,0.0977257894843719,0.634569807939241
CR2,Complement receptor type 2,Diet and food preferences,X20705.Liking for potatoes,36292,0.0562586253576361,0.0410391776359718,-0.0241781628088686,0.136695413524141,0.170464591295023
CR2,Complement receptor type 2,Diet and food preferences,X20706.Liking for prawns,36292,-0.0537360129182422,0.0407323908462171,-0.133571498976828,0.0260994731403433,0.187129745247366
CR2,Complement receptor type 2,Diet and food preferences,X20707.Liking for raw carrots,36292,0.0784729392231059,0.0405217864708213,-0.00094976225970371,0.157895640705916,0.0528386370745311
CR2,Complement receptor type 2,Diet and food preferences,X20708.Liking for red meat,36292,-0.043647795623331,0.0408216720800039,-0.123658272900139,0.0363626816534766,0.285002017104066
CR2,Complement receptor type 2,Diet and food preferences,X20709.Liking for red wine,36292,-0.148596503240353,0.0403465091026122,-0.227675661081472,-0.0695173453992327,0.000232213601155569
CR2,Complement receptor type 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36292,0.0211116255092638,0.0417134985522521,-0.0606468316531503,0.102870082671678,0.612795055138909
CR2,Complement receptor type 2,Diet and food preferences,X20711.Liking for roast chicken,36292,0.0065972680279099,0.0425124902231938,-0.0767272128095499,0.0899217488653697,0.876680499068748
CR2,Complement receptor type 2,Diet and food preferences,X20712.Liking for salad dressing,36292,-0.0352785389911017,0.0401882661644616,-0.114047540673446,0.043490462691243,0.380064740845864
CR2,Complement receptor type 2,Diet and food preferences,X20713.Liking for salad leaves,36292,-0.00269073986718845,0.0410861924854877,-0.0832196771387443,0.0778381974043675,0.947785615522229
CR2,Complement receptor type 2,Diet and food preferences,X20714.Liking for salami,36292,-0.0416173267216478,0.0400734701779586,-0.120161328270447,0.0369266748271511,0.299060819706398
CR2,Complement receptor type 2,Diet and food preferences,X20715.Liking for salmon,36292,0.000264015676478115,0.042588577935711,-0.0832095970775154,0.0837376284304717,0.995053949576971
CR2,Complement receptor type 2,Diet and food preferences,X20716.Liking for salty foods,36292,-0.0358139681322046,0.0399097643806336,-0.114037106318246,0.0424091700538372,0.369550080004399
CR2,Complement receptor type 2,Diet and food preferences,X20717.Liking for salty pretzels,36292,-0.0697001136293104,0.0400428909845526,-0.148184179959033,0.00878395270041264,0.0817907212151818
CR2,Complement receptor type 2,Diet and food preferences,X20718.Liking for sardines,36292,-0.0480173960387316,0.0402015344884169,-0.126812403636029,0.0307776115585655,0.232354854115301
CR2,Complement receptor type 2,Diet and food preferences,X20719.Liking for sausages (meat),36292,-0.0473990523720167,0.0405571566264075,-0.126891079359775,0.0320929746157419,0.242564780332169
CR2,Complement receptor type 2,Diet and food preferences,X20720.Liking for savoury biscuits,36292,0.0192603616470236,0.0403636008876391,-0.0598522960927489,0.0983730193867962,0.633254684218638
CR2,Complement receptor type 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36292,-0.0621217320830919,0.0402800160566209,-0.141070563554069,0.0168270993878852,0.123058228865817
CR2,Complement receptor type 2,Diet and food preferences,X20722.Liking for skimmed milk,36292,0.000450189426440172,0.0399675407259437,-0.0778861903964095,0.0787865692492899,0.99101323416981
CR2,Complement receptor type 2,Diet and food preferences,X20723.Liking for smoked fish,36292,0.0110700010138966,0.0399942087151844,-0.0673186480678648,0.089458650095658,0.781949353421291
CR2,Complement receptor type 2,Diet and food preferences,X20724.Liking for soft cheese,36292,0.00146598933117029,0.0402909205940274,-0.0775042150331234,0.080436193695464,0.970976316165611
CR2,Complement receptor type 2,Diet and food preferences,X20725.Liking for soy sauce,36292,-0.0897454480353059,0.0401982993758078,-0.168534114811889,-0.0109567812587227,0.0256085343217626
CR2,Complement receptor type 2,Diet and food preferences,X20726.Liking for soya milk,36292,0.0714707563622936,0.040959830906645,-0.00881051221473059,0.151752024939318,0.0810458327757142
CR2,Complement receptor type 2,Diet and food preferences,X20727.Liking for spicy foods,36292,-0.063708872257735,0.0399218479961634,-0.141955694330215,0.0145379498147453,0.110569149132417
CR2,Complement receptor type 2,Diet and food preferences,X20728.Liking for spinach,36292,0.0320158274682536,0.0403598786754432,-0.0470895347356151,0.111121189672122,0.427653625434293
CR2,Complement receptor type 2,Diet and food preferences,X20729.Liking for spirits,36292,-0.124024835084751,0.0400657894540974,-0.202553782414782,-0.0454958877547198,0.00197227938756634
CR2,Complement receptor type 2,Diet and food preferences,X20730.Liking for strawberries,36292,0.0161406701653982,0.0440419165515828,-0.0701814862757041,0.1024628266065,0.714014676440208
CR2,Complement receptor type 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36292,-0.0121914945585274,0.041411550118281,-0.0933581327903582,0.0689751436733035,0.768462100710119
CR2,Complement receptor type 2,Diet and food preferences,X20732.Liking for sweet foods,36292,0.0290551115612595,0.0400298052586276,-0.0494033067456506,0.10751352986817,0.467962696720533
CR2,Complement receptor type 2,Diet and food preferences,X20733.Liking for taking the stairs,36292,-0.0107823842143138,0.0406021787036402,-0.0903626544734486,0.0687978860448211,0.790584496082632
CR2,Complement receptor type 2,Diet and food preferences,X20734.Liking for tea with sugar,36292,-0.061526641095466,0.049262244381833,-0.158080640083859,0.0350273578929267,0.211720437260246
CR2,Complement receptor type 2,Diet and food preferences,X20735.Liking for tea without sugar,36292,-0.0130861518572867,0.0420739579414723,-0.0955511094225723,0.0693788057079989,0.755788970877398
CR2,Complement receptor type 2,Diet and food preferences,X20736.Liking for tomato ketchup,36292,-0.0164633335416709,0.0403006640927694,-0.0954526351634989,0.062525968080157,0.682909639583665
CR2,Complement receptor type 2,Diet and food preferences,X20737.Liking for tinned tuna,36292,0.00404257581567103,0.0404222744726426,-0.0751850821507085,0.0832702337820505,0.920340311365019
CR2,Complement receptor type 2,Diet and food preferences,X20738.Liking for turnip (white),36292,0.00152733691980551,0.0398466745175041,-0.0765721451345025,0.0796268189741135,0.969425373292425
CR2,Complement receptor type 2,Diet and food preferences,X20739.Liking for vegetables,36292,0.0797928590135178,0.0449311465240544,-0.00827218817362886,0.167857906200664,0.075793623563271
CR2,Complement receptor type 2,Diet and food preferences,X20740.Liking for vinegar,36292,-0.00923349229207161,0.040720097391492,-0.0890448831793959,0.0705778985952526,0.820620668969513
CR2,Complement receptor type 2,Diet and food preferences,X20741.Liking for watching television,36292,0.00666559411685058,0.0403164904198294,-0.072354727106015,0.0856859153397161,0.868687619225001
CR2,Complement receptor type 2,Diet and food preferences,X20742.Liking for whisky,36292,-0.128581313322079,0.0410856198376146,-0.209109128203804,-0.0480534984403549,0.00175758650652016
CR2,Complement receptor type 2,Diet and food preferences,X20743.Liking for white bread,36292,0.0105850981133363,0.0401341237867434,-0.0680777845086808,0.0892479807353533,0.791985550117427
CR2,Complement receptor type 2,Diet and food preferences,X20744.Liking for white rice,36292,-0.0442370619877421,0.0406353155468444,-0.123882280459557,0.0354081564840728,0.276351500968564
CR2,Complement receptor type 2,Diet and food preferences,X20745.Liking for white wine,36292,-0.128352598083437,0.0400821090987062,-0.206913531916901,-0.0497916642499731,0.00136965015736424
CR2,Complement receptor type 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36292,0.0574298049790375,0.0409190861395156,-0.0227716038544131,0.137631213812488,0.16051255711207
CR2,Complement receptor type 2,Diet and food preferences,X20747.Liking for whole milk,36292,0.0120475220521934,0.0398948779077685,-0.0661464386470329,0.0902414827514197,0.762674891118025
CR2,Complement receptor type 2,Diet and food preferences,X20748.Liking for wholemeal bread,36292,-0.0115488205027309,0.0424808575119586,-0.0948113012261697,0.0717136602207079,0.785738045505304
CR2,Complement receptor type 2,Diet and food preferences,X20749.Liking for working up a sweat,36292,-0.0500998914213423,0.040158168214784,-0.128809901122319,0.0286101182796344,0.212231920044989
CR2,Complement receptor type 2,Physical measures,X21001.Body mass index (BMI),52369,-0.062212856677479,0.0165947297853582,-0.0947385270567811,-0.0296871862981769,0.000178005974126023
CR2,Complement receptor type 2,Physical measures,X21002.Weight,52388,0.0258824405324583,0.00889551290144741,0.00844723524562137,0.0433176458192952,0.00362228054618095
CR2,Complement receptor type 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,37101,0.00428906903661052,0.0060480453564859,-0.00756509986210183,0.0161432379353229,0.478242286174577
CR2,Complement receptor type 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36092,0.0665273391801686,0.0434011105874466,-0.0185388375712267,0.151593515931564,0.125359012255412
CR2,Complement receptor type 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36108,-0.0927054567747538,0.0441394347739001,-0.179218748931598,-0.00619216461790971,0.0357397979202613
CR2,Complement receptor type 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36110,0.0121143758890067,0.0434542653826854,-0.0730559842610567,0.0972847360390701,0.780418544794012
CR2,Complement receptor type 2,Health and medical history,X21040.Satisfaction with bowel habits,36065,0.0207136483025183,0.0401625282184203,-0.0580049070055855,0.099432203610622,0.606048698711803
CR2,Complement receptor type 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36047,0.123729244934132,0.0434877978661274,0.0384931611165221,0.208965328751742,0.00445225444773346
CR2,Complement receptor type 2,Health and medical history,X21042.Greatest number of times bowels opened per day,36064,0.0443733618325837,0.0426579900319191,-0.0392362986299778,0.127983022295145,0.298277934452154
CR2,Complement receptor type 2,Health and medical history,X21043.Least number of times bowels opened per week,35998,-0.0176255539421022,0.0428105530627038,-0.101534237945002,0.0662831300607973,0.68056460300987
CR2,Complement receptor type 2,Health and medical history,X21044.Average number of times bowels opened per day,36029,0.096288826435634,0.0487295760873233,0.000778857304480421,0.191798795566788,0.0481968713924421
CR2,Complement receptor type 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36114,0.063311836174104,0.0441658126912305,-0.0232531567007078,0.149876829048916,0.151759255453948
CR2,Complement receptor type 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36109,-0.00478348383766892,0.0442724172213088,-0.0915574215914341,0.0819904539160962,0.913961867929911
CR2,Complement receptor type 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32826,0.139054508466804,0.0778351368543042,-0.0135023597676328,0.29161137670124,0.074097510528946
CR2,Complement receptor type 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36112,0.0915089368172867,0.05045808837812,-0.00738891640382858,0.190406790038402,0.0697883034168081
CR2,Complement receptor type 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36111,-0.107791636855225,0.0661606686448123,-0.237466547399057,0.0218832736886076,0.103307672241634
CR2,Complement receptor type 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36110,-0.0760546065094915,0.0506040180664965,-0.175238481919825,0.0231292689008416,0.132901182534828
CR2,Complement receptor type 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36109,-0.0676819127043208,0.126013556447542,-0.314668483341502,0.179304657932861,0.591215651406171
CR2,Complement receptor type 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36115,-0.0207591345732935,0.0515560513217219,-0.121808995163868,0.0802907260172815,0.6872168675579
CR2,Complement receptor type 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36111,-0.0403951743375843,0.0477019088478976,-0.133890915679464,0.053100567004295,0.397121909677965
CR2,Complement receptor type 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35950,0.0648957114184847,0.0457280868690156,-0.0247313388447858,0.154522761681755,0.155896994067392
CR2,Complement receptor type 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36105,-0.0290273745939053,0.0439422050935008,-0.115154096577167,0.0570993473893563,0.508903240881689
CR2,Complement receptor type 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36111,-0.0160746276616689,0.0700087155039853,-0.15329171004948,0.121142454726142,0.818402441550443
CR2,Complement receptor type 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36116,-0.0620755777913091,0.0441658795701746,-0.148640701748851,0.0244895461662332,0.159914615761764
CR2,Complement receptor type 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36115,-0.0951350014092341,0.0439105510614085,-0.181199681489595,-0.00907032132887346,0.030302165670461
CR2,Complement receptor type 2,Working and living environment,X21100.Water hardness (USGS classification),52340,0.00522271449089786,0.0232123392432854,-0.0402734704259416,0.0507188994077373,0.821983333158393
CR2,Complement receptor type 2,Lifestyle factors,X2139.Age first had sexual intercourse,48528,0.0154805503538648,0.00407274184097528,0.00749797634555323,0.0234631243621763,0.000144547006166867
CR2,Complement receptor type 2,Health and medical history,X2149.Lifetime number of sexual partners,47323,-0.097676491353209,0.0264550857973161,-0.149528459515948,-0.0458245231904695,0.000223006986286121
CR2,Complement receptor type 2,Physical activities,X22032.IPAQ activity group,47304,-0.0377554840307186,0.0262610962120127,-0.0892272326062636,0.0137162645448264,0.150537488145115
CR2,Complement receptor type 2,Physical activities,X22033.Summed days activity,47817,-0.00851884559680358,0.00400048375953327,-0.0163597937654888,-0.000677897428118378,0.0332298058520166
CR2,Complement receptor type 2,Physical activities,X22034.Summed minutes activity,47304,-0.00793600455345834,0.00397176011432418,-0.0157206543775337,-0.000151354729382942,0.0457199092778326
CR2,Complement receptor type 2,Physical activities,X22037.MET minutes per week for walking,46309,-0.00572650841470011,0.00425892478407193,-0.0140740009914811,0.00262098416208088,0.178775437512769
CR2,Complement receptor type 2,Physical activities,X22038.MET minutes per week for moderate activity,47304,-0.00423103931703976,0.00387370085458129,-0.0118234929920191,0.00336141435793957,0.274738945019989
CR2,Complement receptor type 2,Physical activities,X22039.MET minutes per week for vigorous activity,47304,-0.0647346708009698,0.0263415269981709,-0.116364063717385,-0.0131052778845549,0.0139995398757371
CR2,Complement receptor type 2,Physical activities,X22040.Summed MET minutes per week for all activity,46309,-0.00755561001528286,0.00413264651170391,-0.0156555971782225,0.000544377147656815,0.0675258419902067
CR2,Complement receptor type 2,Eye measures,X2217.Age started wearing glasses or contact lenses,50487,0.000230571488724599,0.00335474864250808,-0.00634473585059124,0.00680587882804044,0.945205274944976
CR2,Complement receptor type 2,Working and living environment,X22501.Year ended full time education,34172,-0.0166312102149436,0.0169526706065189,-0.0498584446037206,0.0165960241738334,0.326621790217386
CR2,Complement receptor type 2,Lifestyle factors,X22506.Tobacco smoking,34140,-0.00252891470058843,0.103214084675528,-0.204828520664623,0.199770691263446,0.980453461652402
CR2,Complement receptor type 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51156,-0.140387182737522,0.0866249845998626,-0.310172152553253,0.0293977870782088,0.105111039544407
CR2,Complement receptor type 2,Physical measures,X23098.Weight,51897,0.0271568826278441,0.0089853834102832,0.00954553114368904,0.0447682341119992,0.00251108340314838
CR2,Complement receptor type 2,Physical measures,X23099.Body fat percentage,51889,0.013342174624721,0.00855124199847664,-0.00341825969229323,0.0301026089417352,0.118712014536707
CR2,Complement receptor type 2,Physical measures,X23100.Whole body fat mass,51873,0.0279275806396428,0.00843281163792969,0.0113992698293006,0.044455891449985,0.000928506862457448
CR2,Complement receptor type 2,Physical measures,X23101.Whole body fat-free mass,51897,0.0172025055757901,0.00732680517138094,0.0028419674398835,0.0315630437116968,0.0188888183682927
CR2,Complement receptor type 2,Physical measures,X23102.Whole body water mass,51897,0.0169229563417463,0.00735227361590026,0.00251250005458183,0.0313334126289109,0.0213593532694132
CR2,Complement receptor type 2,Physical measures,X23104.Body mass index (BMI),51897,-0.0645844598494396,0.0166150686817839,-0.0971499944657361,-0.0320189252331431,0.0001017366660267
CR2,Complement receptor type 2,Physical measures,X23105.Basal metabolic rate,51897,0.0192134515948588,0.00782502681980692,0.00387639902803723,0.0345505041616804,0.0140808286993362
CR2,Complement receptor type 2,Physical measures,X23106.Impedance of whole body,51894,0.0108764562584416,0.00597265255829159,-0.000829942755809972,0.0225828552726931,0.0686135005086324
CR2,Complement receptor type 2,Physical measures,X23107.Impedance of leg (right),51897,0.00839872024086763,0.00482223056559907,-0.00105285166770655,0.0178502921494418,0.0815802593760732
CR2,Complement receptor type 2,Physical measures,X23108.Impedance of leg (left),51897,0.0079622797339405,0.00479193540288771,-0.0014299136557194,0.0173544731236004,0.0966068155842577
CR2,Complement receptor type 2,Physical measures,X23109.Impedance of arm (right),51894,0.00670493474696014,0.00589792530799398,-0.00485499885670805,0.0182648683506283,0.25562162080571
CR2,Complement receptor type 2,Physical measures,X23110.Impedance of arm (left),51897,0.00767590171420826,0.00592412829421284,-0.0039353897424489,0.0192871931708654,0.195091529288574
CR2,Complement receptor type 2,Physical measures,X23111.Leg fat percentage (right),51897,-0.00163824261029369,0.0100292127841143,-0.0212954996671578,0.0180190144465704,0.870246622119224
CR2,Complement receptor type 2,Physical measures,X23112.Leg fat mass (right),51897,0.0405288680418958,0.0109897040145292,0.0189890481734186,0.0620686879103729,0.000226644614446645
CR2,Complement receptor type 2,Physical measures,X23113.Leg fat-free mass (right),51896,0.0182256277528483,0.00744814443551398,0.00362726465924092,0.0328239908464557,0.0144125121261941
CR2,Complement receptor type 2,Physical measures,X23114.Leg predicted mass (right),51896,0.0177605949668836,0.00749437972680642,0.003071610702343,0.0324495792314242,0.0178033623250721
CR2,Complement receptor type 2,Physical measures,X23115.Leg fat percentage (left),51894,-0.00544680561960677,0.0105452430184214,-0.0261154819357128,0.0152218706964992,0.605497848702669
CR2,Complement receptor type 2,Physical measures,X23116.Leg fat mass (left),51894,0.0376402042380207,0.0115153149334355,0.015070186968487,0.0602102215075543,0.00108200330894729
CR2,Complement receptor type 2,Physical measures,X23117.Leg fat-free mass (left),51893,0.0219662814752705,0.00783779913347159,0.00660419517366614,0.0373283677768748,0.00507341444866383
CR2,Complement receptor type 2,Physical measures,X23118.Leg predicted mass (left),51893,0.022213691925284,0.00788688594750373,0.00675539546817666,0.0376719883823913,0.00485866084079318
CR2,Complement receptor type 2,Physical measures,X23119.Arm fat percentage (right),51893,-0.0118404598947229,0.00964266280322442,-0.0307400789890428,0.00705915919959691,0.219488122175583
CR2,Complement receptor type 2,Physical measures,X23120.Arm fat mass (right),51891,-0.00118243950296974,0.00963009871332486,-0.0200574329810865,0.017692553975147,0.902277795701312
CR2,Complement receptor type 2,Physical measures,X23121.Arm fat-free mass (right),51892,0.0237106394942995,0.00749200514619059,0.00902630940776597,0.0383949695808331,0.00155398619285634
CR2,Complement receptor type 2,Physical measures,X23122.Arm predicted mass (right),51892,0.0232510982029452,0.00750651068412136,0.00853833726206729,0.037963859143823,0.00195426443823323
CR2,Complement receptor type 2,Physical measures,X23123.Arm fat percentage (left),51891,-0.00380087157908202,0.00988197670077863,-0.0231695459126081,0.0155678027544441,0.700517651233197
CR2,Complement receptor type 2,Physical measures,X23124.Arm fat mass (left),51891,0.00639071738735641,0.00964595872373669,-0.0125153617111675,0.0252967964858803,0.507639647108896
CR2,Complement receptor type 2,Physical measures,X23125.Arm fat-free mass (left),51891,0.0191665789195434,0.00764719882819514,0.00417806921628094,0.0341550886228059,0.0122053173563005
CR2,Complement receptor type 2,Physical measures,X23126.Arm predicted mass (left),51889,0.0162694696360261,0.00765340783359638,0.00126879028217724,0.031270148989875,0.0335322576212416
CR2,Complement receptor type 2,Physical measures,X23127.Trunk fat percentage,51888,0.0128987531037484,0.0061238132246693,0.000896079183396556,0.0249014270241002,0.0351869086605926
CR2,Complement receptor type 2,Physical measures,X23128.Trunk fat mass,51888,0.0252044339785294,0.00684396293684837,0.0117902666223066,0.0386186013347522,0.000231289343871635
CR2,Complement receptor type 2,Physical measures,X23129.Trunk fat-free mass,51887,0.0110170874661817,0.0066128858667951,-0.00194416883273668,0.0239783437651001,0.0957266256091889
CR2,Complement receptor type 2,Physical measures,X23130.Trunk predicted mass,51884,0.0107788770134628,0.00663222665012759,-0.00222028722078725,0.0237780412477129,0.104127985423174
CR2,Complement receptor type 2,NMR metabolomics,X23400.Total Cholesterol,42689,-0.0371511465555856,0.00472835827050997,-0.0464187287657852,-0.0278835643453861,4.22780562014e-15
CR2,Complement receptor type 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42689,-0.0149471231552739,0.00459758082586966,-0.0239583815739785,-0.0059358647365694,0.00115247714918196
CR2,Complement receptor type 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42689,-0.00634491166221067,0.00459167999058903,-0.0153446044437652,0.00265478111934383,0.167047414139231
CR2,Complement receptor type 2,NMR metabolomics,X23403.VLDL Cholesterol,42689,0.0176579128318831,0.00466681428650599,0.00851095683033133,0.0268048688334348,0.000155170167725581
CR2,Complement receptor type 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42689,-0.0226072258859523,0.00459177529095171,-0.0316071054562177,-0.013607346315687,8.60514890017018e-07
CR2,Complement receptor type 2,NMR metabolomics,X23405.LDL Cholesterol,42689,-0.0220659430599363,0.00461351826476297,-0.0311084388588717,-0.0130234472610009,1.74620891337351e-06
CR2,Complement receptor type 2,NMR metabolomics,X23406.HDL Cholesterol,42689,-0.0889271037048004,0.00523900985359675,-0.09919556301785,-0.0786586443917508,5.88572038197224e-64
CR2,Complement receptor type 2,NMR metabolomics,X23407.Total Triglycerides,42689,0.0269202218205973,0.00503784391530955,0.0170460477465905,0.036794395894604,9.25998604330407e-08
CR2,Complement receptor type 2,NMR metabolomics,X23408.Triglycerides in VLDL,42689,0.0295450127460078,0.0050184719474684,0.0197088077289697,0.0393812177630458,4.0199851963872e-09
CR2,Complement receptor type 2,NMR metabolomics,X23409.Triglycerides in LDL,42689,0.010781496423535,0.00499731559282478,0.000986757861598466,0.0205762349854716,0.0309876218281785
CR2,Complement receptor type 2,NMR metabolomics,X23410.Triglycerides in HDL,42689,0.0134289887172254,0.0049364945612401,0.00375345937719482,0.023104518057256,0.00652965429601205
CR2,Complement receptor type 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42689,-0.0455057436297451,0.00489549336800322,-0.0551009106310314,-0.0359105766284588,1.68786266672892e-20
CR2,Complement receptor type 2,NMR metabolomics,X23412.Phospholipids in VLDL,42689,0.0260438842087418,0.00481264887210501,0.016611092419416,0.0354766759980676,6.35490302059305e-08
CR2,Complement receptor type 2,NMR metabolomics,X23413.Phospholipids in LDL,42689,-0.0197891921236935,0.00458729836489574,-0.0287802969188891,-0.0107980873284979,1.61532881500491e-05
CR2,Complement receptor type 2,NMR metabolomics,X23414.Phospholipids in HDL,42689,-0.0771505576797401,0.0052185066413803,-0.0873788306968455,-0.0669222846626347,4.4933680440873e-49
CR2,Complement receptor type 2,NMR metabolomics,X23415.Total Esterified Cholesterol,42689,-0.0416736878349928,0.00474899358317549,-0.0509817152580168,-0.0323656604119689,1.90755144602737e-18
CR2,Complement receptor type 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42689,0.0138706287961116,0.00461327503891879,0.00482860971983073,0.0229126478723924,0.0026460616522174
CR2,Complement receptor type 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42689,-0.0193547340273431,0.00462053484088022,-0.0284109823154683,-0.0102984857392179,2.82151840745908e-05
CR2,Complement receptor type 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42689,-0.0900194783316661,0.00521054830089003,-0.100232153001411,-0.0798068036619216,3.64237016814021e-66
CR2,Complement receptor type 2,NMR metabolomics,X23419.Total Free Cholesterol,42689,-0.0255092734931562,0.00468056117254973,-0.0346831733913537,-0.0163353735949588,5.1240946355531e-08
CR2,Complement receptor type 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42689,0.0223962752935687,0.00475928647968336,0.0130680737933893,0.0317244767937481,2.55376753072249e-06
CR2,Complement receptor type 2,NMR metabolomics,X23421.Free Cholesterol in LDL,42689,-0.0285422893949429,0.0046176817290313,-0.0375929455838442,-0.0194916332060416,6.54951593177386e-10
CR2,Complement receptor type 2,NMR metabolomics,X23422.Free Cholesterol in HDL,42689,-0.0794392654930935,0.00530284895805349,-0.0898328494508784,-0.0690456815353087,2.49873755269313e-50
CR2,Complement receptor type 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42689,-0.0245050405055881,0.00472573355177042,-0.0337674782670582,-0.0152426027441181,2.1861373797314e-07
CR2,Complement receptor type 2,NMR metabolomics,X23424.Total Lipids in VLDL,42689,0.0275165240295798,0.00487690670191443,0.0179577868938275,0.0370752611653321,1.71258427207605e-08
CR2,Complement receptor type 2,NMR metabolomics,X23425.Total Lipids in LDL,42689,-0.0200403141180744,0.00461078032996197,-0.0290774435647998,-0.0110031846713489,1.39400336830671e-05
CR2,Complement receptor type 2,NMR metabolomics,X23426.Total Lipids in HDL,42689,-0.081213259815943,0.00524262218702039,-0.0914887993025029,-0.070937720329383,1.156037272373e-53
CR2,Complement receptor type 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42689,-0.0774331909305253,0.00494690267796676,-0.0871291201793402,-0.0677372616817105,9.61597260505344e-55
CR2,Complement receptor type 2,NMR metabolomics,X23428.Concentration of VLDL Particles,42689,0.0201494420935803,0.00474984919869228,0.0108397376641434,0.0294591465230172,2.22892564659771e-05
CR2,Complement receptor type 2,NMR metabolomics,X23429.Concentration of LDL Particles,42689,-0.00201214757868117,0.00457747066642482,-0.0109839900848738,0.00695969492751147,0.660251054224178
CR2,Complement receptor type 2,NMR metabolomics,X23430.Concentration of HDL Particles,42689,-0.0809992397895966,0.00495208110792798,-0.0907053187611354,-0.0712931608180577,1.4588244431971e-59
CR2,Complement receptor type 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42689,0.0366131771055259,0.00510253792020145,0.0266122027819311,0.0466141514291208,7.58124332155203e-13
CR2,Complement receptor type 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42689,-0.0256794605608538,0.00486118114401959,-0.0352073756031321,-0.0161515455185754,1.29374256996305e-07
CR2,Complement receptor type 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42689,-0.0502637676121116,0.00545951281727605,-0.0609644127339727,-0.0395631224902505,3.85382691589528e-20
CR2,Complement receptor type 2,NMR metabolomics,X23434.Phosphoglycerides,42677,-0.0499135758707228,0.00498669423008009,-0.0596874965616798,-0.0401396551797659,1.67484951072607e-23
CR2,Complement receptor type 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42677,0.0570733743255984,0.00521600240096429,0.0468500096197084,0.0672967390314884,9.49729226943486e-28
CR2,Complement receptor type 2,NMR metabolomics,X23436.Total Cholines,42677,-0.0522418916124099,0.00499077099009614,-0.0620238027529984,-0.0424599804718215,1.52301967063284e-25
CR2,Complement receptor type 2,NMR metabolomics,X23437.Phosphatidylcholines,42677,-0.0548768964045453,0.00502606980713271,-0.0647279932265254,-0.0450257995825652,1.22801495431451e-27
CR2,Complement receptor type 2,NMR metabolomics,X23438.Sphingomyelins,42677,-0.0531929111023114,0.00489924158386325,-0.0627954246066834,-0.0435903975979394,2.38701643611825e-27
CR2,Complement receptor type 2,NMR metabolomics,X23439.Apolipoprotein B,42689,-0.00172551890110516,0.00457475817268188,-0.0106920449195616,0.00724100711735132,0.706043886820562
CR2,Complement receptor type 2,NMR metabolomics,X23440.Apolipoprotein A1,42689,-0.0806044101953813,0.00511623313083857,-0.0906322271318249,-0.0705765932589377,1.98877879953637e-55
CR2,Complement receptor type 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42689,0.0368253618859002,0.00467727473065003,0.0276579034138261,0.0459928203579743,3.71798010185351e-15
CR2,Complement receptor type 2,NMR metabolomics,X23442.Total Fatty Acids,42677,-0.0101836766820506,0.00487244633815571,-0.0197336715048358,-0.000633681859265449,0.0366316229916492
CR2,Complement receptor type 2,NMR metabolomics,X23443.Degree of Unsaturation,42677,-0.0275120480674575,0.00495739637433007,-0.0372285449611445,-0.0177955511737706,2.9156316858154e-08
CR2,Complement receptor type 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42677,-0.0141644979272272,0.00491446677556384,-0.0237968528073323,-0.00453214304712209,0.00395527078846185
CR2,Complement receptor type 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42677,-0.0222333939083347,0.00480295000746445,-0.031647175922965,-0.0128196118937043,3.70662942860953e-06
CR2,Complement receptor type 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42677,-0.0234204797582437,0.00486508982188786,-0.0329560558091439,-0.0138849037073434,1.49553585496913e-06
CR2,Complement receptor type 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42677,0.00938963564903742,0.00499427757574608,-0.000399148399424891,0.0191784196974997,0.0601188737395177
CR2,Complement receptor type 2,NMR metabolomics,X23448.Saturated Fatty Acids,42677,-0.0149717181797847,0.00487231890602791,-0.0245214632355994,-0.00542197312396996,0.00212475276350374
CR2,Complement receptor type 2,NMR metabolomics,X23449.Linoleic Acid,42677,-0.0105354748130781,0.00470731010544016,-0.0197618026197408,-0.00130914700641539,0.0252301837986674
CR2,Complement receptor type 2,NMR metabolomics,X23450.Docosahexaenoic Acid,42677,-0.0361220022755391,0.00490123820407054,-0.0457284291555173,-0.0265155753955608,1.80589416279374e-13
CR2,Complement receptor type 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42677,-0.0110207079103402,0.00486642902376478,-0.0205589087969191,-0.00148250702376119,0.0235506108392747
CR2,Complement receptor type 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42677,-0.0132273447606988,0.00522754419204218,-0.0234733313771015,-0.00298135814429615,0.0114072298975034
CR2,Complement receptor type 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42677,-0.0151181151350534,0.00516504822766383,-0.0252416096612745,-0.00499462060883229,0.00342816472510946
CR2,Complement receptor type 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42677,0.0461873153294376,0.00521792732531849,0.0359601777718133,0.0564144528870618,9.68593155571565e-19
CR2,Complement receptor type 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42677,-0.0234076434140037,0.00474156007452052,-0.0327011011600639,-0.0141141856679435,8.04072146483868e-07
CR2,Complement receptor type 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42677,-0.000119620755688515,0.00502780142790101,-0.0099741115543745,0.00973487004299746,0.981018983801192
CR2,Complement receptor type 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42677,-0.0285879931620523,0.00485082321587701,-0.0380956066651712,-0.0190803796589333,3.87290910711472e-09
CR2,Complement receptor type 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42677,-0.0343223113785228,0.00523639250407021,-0.0445856406865004,-0.0240589820705452,5.78313510232207e-11
CR2,Complement receptor type 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42677,0.0058999938694696,0.004814122537301,-0.00353568630364036,0.0153356740425796,0.220385872928441
CR2,Complement receptor type 2,NMR metabolomics,X23460.Alanine,42683,0.0108448124752008,0.00473773250873987,0.00155885675807062,0.0201307681923309,0.022092982496663
CR2,Complement receptor type 2,NMR metabolomics,X23461.Glutamine,42642,-0.0175644897287456,0.00475402892034453,-0.0268823864126209,-0.00824659304487031,0.000221059913734928
CR2,Complement receptor type 2,NMR metabolomics,X23462.Glycine,42673,0.00888361841540838,0.00506221694079388,-0.00103832678854763,0.0188055636193644,0.0793013653629042
CR2,Complement receptor type 2,NMR metabolomics,X23463.Histidine,42669,-0.00493350278286686,0.00467413534122408,-0.0140948080516661,0.00422780248593234,0.291220236144455
CR2,Complement receptor type 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42679,0.0123509151649503,0.00495125791515425,0.00264644965124793,0.0220553806786526,0.0126253295411021
CR2,Complement receptor type 2,NMR metabolomics,X23465.Isoleucine,42685,0.0107196949798374,0.00482417944072664,0.00126430327601316,0.0201750866836616,0.0262946687801074
CR2,Complement receptor type 2,NMR metabolomics,X23466.Leucine,42685,0.00753769326821436,0.00488390720362849,-0.00203476485089748,0.0171101513873262,0.122763618700725
CR2,Complement receptor type 2,NMR metabolomics,X23467.Valine,42679,0.0149475286398251,0.00499873408701605,0.00515000982927368,0.0247450474503766,0.00279240718093557
CR2,Complement receptor type 2,NMR metabolomics,X23468.Phenylalanine,42681,0.0151214340263952,0.00474068931765501,0.00582968296379138,0.024413185088999,0.00142740364345236
CR2,Complement receptor type 2,NMR metabolomics,X23469.Tyrosine,42672,0.0125618732950045,0.00481266976648511,0.00312904055269372,0.0219947060373153,0.00905980470503405
CR2,Complement receptor type 2,NMR metabolomics,X23470.Glucose,42662,0.0203541580971423,0.00467896783477339,0.0111833811409864,0.0295249350532981,1.37052531922847e-05
CR2,Complement receptor type 2,NMR metabolomics,X23471.Lactate,42664,-0.00313354873185684,0.00469133450534513,-0.0123285643623333,0.00606146689861962,0.504180783968878
CR2,Complement receptor type 2,NMR metabolomics,X23472.Pyruvate,42645,-0.0166966098368331,0.00474900438416636,-0.0260046584297992,-0.00738856124386704,0.000439853294675869
CR2,Complement receptor type 2,NMR metabolomics,X23473.Citrate,42686,0.0256945051830779,0.00474822333597057,0.0163879874445756,0.0350010229215803,6.36042737774938e-08
CR2,Complement receptor type 2,NMR metabolomics,X23474.3-Hydroxybutyrate,42464,-0.0116703688987516,0.00499073495855974,-0.0214522094175286,-0.00188852837997447,0.0193809214561572
CR2,Complement receptor type 2,NMR metabolomics,X23475.Acetate,42677,0.0188968333595905,0.00466276164345554,0.00975782053841762,0.0280358461807633,5.09111726524186e-05
CR2,Complement receptor type 2,NMR metabolomics,X23476.Acetoacetate,42687,-0.0157572685275535,0.00479613352537734,-0.0251576902372931,-0.0063568468178139,0.00102093511238072
CR2,Complement receptor type 2,NMR metabolomics,X23477.Acetone,42687,-0.0212129335500676,0.00475652544658452,-0.0305357234253733,-0.0118901436747619,8.27166067767711e-06
CR2,Complement receptor type 2,NMR metabolomics,X23478.Creatinine,42375,0.0444808189852071,0.0053127864225723,0.0340677575969654,0.0548938803734488,6.21093637421083e-17
CR2,Complement receptor type 2,NMR metabolomics,X23479.Albumin,42686,0.0131706413636719,0.00474438689563469,0.00387164304822789,0.0224696396791159,0.00551000603125731
CR2,Complement receptor type 2,NMR metabolomics,X23480.Glycoprotein Acetyls,42689,0.0154445894937599,0.0050298716057114,0.00558604114656551,0.0253031378409542,0.00214072877166486
CR2,Complement receptor type 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42689,0.0379735621688794,0.00505364062223205,0.0280684265493046,0.0478786977884542,6.0905855981096e-14
CR2,Complement receptor type 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42689,0.0370542162023748,0.00499929924616547,0.0272555896798905,0.0468528427248591,1.31925212651985e-13
CR2,Complement receptor type 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42689,0.0388025431928121,0.0050623605636896,0.0288803164879805,0.0487247698976438,1.91148361155057e-14
CR2,Complement receptor type 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42689,0.0373314984957983,0.00501756183422219,0.0274970773007228,0.0471659196908738,1.06631390960753e-13
CR2,Complement receptor type 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42689,0.0374790495104287,0.00495802736848225,0.0277613158682035,0.047196783152654,4.31455830640954e-14
CR2,Complement receptor type 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42689,0.0367974763127943,0.00506426467017107,0.026871517559259,0.0467234350663296,3.90313372691051e-13
CR2,Complement receptor type 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42689,0.034435408030228,0.00495407588969662,0.0247254192864227,0.0441453967740334,3.79570345795572e-12
CR2,Complement receptor type 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42689,0.0342825506721763,0.00503571950503079,0.024412540442316,0.0441525609020367,1.03237517164089e-11
CR2,Complement receptor type 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42689,0.0343273883398593,0.00501083527523125,0.0245061512004061,0.0441486254793126,7.67110976034077e-12
CR2,Complement receptor type 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42689,0.0370801180627688,0.00499247875011078,0.0272948597125517,0.046865376412986,1.17576323451405e-13
CR2,Complement receptor type 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42689,0.033886175427186,0.00488127350449842,0.0243188793583691,0.0434534714960029,4.04035852739172e-12
CR2,Complement receptor type 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42689,0.0303239042103747,0.00480621174084338,0.0209037291983217,0.0397440792224278,2.89026925320336e-10
CR2,Complement receptor type 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42689,0.0366626239234013,0.00495461994715455,0.0269515688269784,0.0463736790198242,1.44573447418997e-13
CR2,Complement receptor type 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42689,0.0313742536643788,0.00504215260301723,0.021491634562465,0.0412568727662926,5.0410500579415e-10
CR2,Complement receptor type 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42689,0.0320932136192604,0.00497576090457305,0.0223407222462972,0.0418457049922236,1.1573096179602e-10
CR2,Complement receptor type 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42689,0.0303978265266088,0.00494960209479115,0.0206966064208182,0.0400990466323995,8.40571925274537e-10
CR2,Complement receptor type 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42689,0.0345387001370741,0.00497206302489548,0.024793456608279,0.0442839436658693,3.91470768943692e-12
CR2,Complement receptor type 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42689,0.0322018854522902,0.00487393987041442,0.0226489633062779,0.0417548075983024,4.07029289541409e-11
CR2,Complement receptor type 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42689,0.0303553843768118,0.00478994100263655,0.0209671000116442,0.0397436687419795,2.41229153321102e-10
CR2,Complement receptor type 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42689,0.0331870638099396,0.00496291222114872,0.0234597558564881,0.0429143717633911,2.36733537915646e-11
CR2,Complement receptor type 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42689,0.0253750751172143,0.00494774784263987,0.0156774893456402,0.0350726608887884,2.9593132511867e-07
CR2,Complement receptor type 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42689,0.0128816722754355,0.00467318008186463,0.00372223931498081,0.0220411052358901,0.00585001100922069
CR2,Complement receptor type 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42689,0.0152991211705385,0.00472340517625251,0.00604124702508357,0.0245569953159934,0.00120238702609209
CR2,Complement receptor type 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42689,0.0114635344840859,0.00465347497994614,0.00234272352339147,0.0205843454447803,0.0137736581186051
CR2,Complement receptor type 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42689,-0.000863111956711974,0.00457018580293086,-0.00982067613045646,0.00809445221703251,0.850207671429704
CR2,Complement receptor type 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42689,-0.00761711838906856,0.00458263503800626,-0.0165990830635608,0.00136484628542372,0.0965019223922881
CR2,Complement receptor type 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42689,0.00764980804933954,0.00462119097441787,-0.00140772626051949,0.0167073423591986,0.0978715287931973
CR2,Complement receptor type 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42689,0.0226861579644402,0.00490471334161633,0.0130729198148722,0.0322993961140082,3.77388432023727e-06
CR2,Complement receptor type 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42689,0.0264626211331102,0.0048209586305633,0.0170135422172061,0.0359117000490143,4.11330212887671e-08
CR2,Complement receptor type 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42689,0.0227790594615025,0.00480859199989011,0.0133542191417179,0.0322038997812871,2.18944312348114e-06
CR2,Complement receptor type 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42689,0.0137959285460822,0.00469706102266503,0.0045896889416587,0.0230021681505056,0.00331813683074236
CR2,Complement receptor type 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42689,0.0151933662035558,0.00465158839829496,0.00607625294289768,0.0243104794642139,0.00109244351007693
CR2,Complement receptor type 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42689,0.0201270010134302,0.00467432985036484,0.0109653145067152,0.0292886875201453,1.67514137008387e-05
CR2,Complement receptor type 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42689,0.00611655841600663,0.00461828488580391,-0.00293527996016904,0.0151683967921823,0.185385338603053
CR2,Complement receptor type 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42689,0.0287010835968138,0.00499093295982847,0.01891885499555,0.0384833121980776,9.08298954797873e-09
CR2,Complement receptor type 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42689,0.00759161654082038,0.00469672146771915,-0.00161395753590916,0.0167971906175499,0.106038779428145
CR2,Complement receptor type 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42689,0.00725827498247292,0.00474216486219529,-0.00203636814742985,0.0165529181123757,0.125896026355094
CR2,Complement receptor type 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42689,0.012775900830807,0.00474632949687868,0.00347309501692481,0.0220787066446892,0.00711672699215621
CR2,Complement receptor type 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42689,-0.00501451268991519,0.00467615483300106,-0.0141797761625973,0.00415075078276688,0.283578378922075
CR2,Complement receptor type 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42689,-0.00935733987908522,0.00468024124963686,-0.0185306127283735,-0.000184067029796973,0.0455928328957849
CR2,Complement receptor type 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42689,0.00533460193766681,0.00470452391322492,-0.00388626493225403,0.0145554688075876,0.256843953121065
CR2,Complement receptor type 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42689,0.024729950328468,0.00498810974031049,0.0149532552374595,0.0345066454194766,7.21694426552471e-07
CR2,Complement receptor type 2,NMR metabolomics,X23523.Concentration of IDL Particles,42689,-0.0125047132497812,0.00454799918874317,-0.0214187916597179,-0.00359063483984463,0.00597661130668359
CR2,Complement receptor type 2,NMR metabolomics,X23524.Total Lipids in IDL,42689,-0.0278202304685817,0.00467474679229625,-0.0369827341814823,-0.018657726755681,2.72827082482698e-09
CR2,Complement receptor type 2,NMR metabolomics,X23525.Phospholipids in IDL,42689,-0.0222066929310599,0.00468926591538724,-0.0313976541252189,-0.013015731736901,2.20582640727434e-06
CR2,Complement receptor type 2,NMR metabolomics,X23526.Cholesterol in IDL,42689,-0.032273576269284,0.00466982562250985,-0.0414264344894033,-0.0231207180491647,5.02541048418444e-12
CR2,Complement receptor type 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42689,-0.0334332698072263,0.00467239745738985,-0.0425911688237104,-0.0242753707907422,8.76805313588073e-13
CR2,Complement receptor type 2,NMR metabolomics,X23528.Free Cholesterol in IDL,42689,-0.0282203777865575,0.0046608944093274,-0.0373557308288392,-0.0190850247442758,1.44401457190726e-09
CR2,Complement receptor type 2,NMR metabolomics,X23529.Triglycerides in IDL,42689,0.0137835218120955,0.00499054731718403,0.00400204907041479,0.0235649945537762,0.00575392399771257
CR2,Complement receptor type 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42689,-0.0042232511089228,0.00457591197429953,-0.0131920385785499,0.00474553636070428,0.35605965406296
CR2,Complement receptor type 2,NMR metabolomics,X23531.Total Lipids in Large LDL,42689,-0.0257376819118456,0.00463439726803377,-0.0348211005571918,-0.0166542632664994,2.85101416828855e-08
CR2,Complement receptor type 2,NMR metabolomics,X23532.Phospholipids in Large LDL,42689,-0.0252631027377605,0.00460223878952624,-0.034283490765232,-0.0162427147102891,4.10799476148644e-08
CR2,Complement receptor type 2,NMR metabolomics,X23533.Cholesterol in Large LDL,42689,-0.027514269008248,0.00464320058104736,-0.0366149421471008,-0.0184135958693952,3.18527842618198e-09
CR2,Complement receptor type 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42689,-0.0256499090543699,0.00464391478108438,-0.0347519820252952,-0.0165478360834445,3.38772869016955e-08
CR2,Complement receptor type 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42689,-0.03189355446463,0.00464891530510285,-0.0410054284626315,-0.0227816804666284,7.16465571397989e-12
CR2,Complement receptor type 2,NMR metabolomics,X23536.Triglycerides in Large LDL,42689,0.00627181693886566,0.00498586750547023,-0.003500483371856,0.0160441172495873,0.208442855034879
CR2,Complement receptor type 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42689,-0.00120441650323722,0.0046082981810915,-0.0102366809381766,0.00782784793170211,0.793820279427643
CR2,Complement receptor type 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42689,-0.0117931001713583,0.00462960931467337,-0.0208671344281181,-0.00271906591459855,0.0108663551731658
CR2,Complement receptor type 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42689,-0.0128131018888688,0.00461928628494797,-0.0218669030073668,-0.00375930077037078,0.00554772008590902
CR2,Complement receptor type 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42689,-0.0131529352002696,0.00461998715729362,-0.0222081100285651,-0.00409776037197407,0.00442050176677057
CR2,Complement receptor type 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42689,-0.00901510350795547,0.00464551426738196,-0.0181203114720241,9.01044561131738e-05,0.0523271290231574
CR2,Complement receptor type 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42689,-0.0234159435337062,0.00460203260189298,-0.0324359274334164,-0.0143959596339959,3.66384248438644e-07
CR2,Complement receptor type 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42689,0.0140606518288009,0.00500562121957279,0.00424963423843823,0.0238716694191636,0.00497713508935244
CR2,Complement receptor type 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42689,0.00632500596591484,0.00457984924648707,-0.00265149855719982,0.0153015104890295,0.16728610922456
CR2,Complement receptor type 2,NMR metabolomics,X23545.Total Lipids in Small LDL,42689,-0.00665543460500197,0.00458322031650517,-0.0156385464253521,0.00232767721534816,0.146488534752612
CR2,Complement receptor type 2,NMR metabolomics,X23546.Phospholipids in Small LDL,42689,-0.00902223538223103,0.00454516950166357,-0.0179307676054916,-0.000113703158970423,0.0471628743140283
CR2,Complement receptor type 2,NMR metabolomics,X23547.Cholesterol in Small LDL,42689,-0.0088669676863511,0.00458323408559769,-0.0178501064941226,0.000116171121420372,0.0530537625458515
CR2,Complement receptor type 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42689,-0.0042876123645308,0.0046122842528453,-0.0133276895001076,0.00475246477104599,0.352591157947234
CR2,Complement receptor type 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42689,-0.0193554577381217,0.00456719319863109,-0.0283071564074386,-0.0104037590688047,2.27086227489874e-05
CR2,Complement receptor type 2,NMR metabolomics,X23550.Triglycerides in Small LDL,42689,0.0257358447239468,0.00503302441622158,0.0158711168681525,0.0356005725797411,3.20752166973888e-07
CR2,Complement receptor type 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42689,-0.0372247778248216,0.00523523891912175,-0.0474858461063002,-0.026963709543343,1.21506075406434e-12
CR2,Complement receptor type 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42689,-0.0365621882477676,0.00526312527325957,-0.0468779137833563,-0.0262464627121788,3.90626904806683e-12
CR2,Complement receptor type 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42689,-0.0340322413235442,0.00530089101926565,-0.0444219877213049,-0.0236424949257835,1.40743988134846e-10
CR2,Complement receptor type 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42689,-0.041845442219363,0.00520301161499139,-0.0520433449847461,-0.0316475394539799,9.52872009998011e-16
CR2,Complement receptor type 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42689,-0.0480950641269284,0.00525117467805327,-0.0583873664959128,-0.0378027617579439,5.98727542400484e-20
CR2,Complement receptor type 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42689,-0.0194485174579519,0.00499272944904547,-0.029234267178081,-0.00966276773782274,9.8522802136644e-05
CR2,Complement receptor type 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42689,0.0155490554176966,0.00491113584696151,0.00592322915765202,0.0251748816777412,0.00154851272336263
CR2,Complement receptor type 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42689,-0.0708031931568519,0.00544284501255927,-0.081471169381468,-0.0601352169322357,1.86436424475205e-38
CR2,Complement receptor type 2,NMR metabolomics,X23559.Total Lipids in Large HDL,42689,-0.0708029262577759,0.00545237427563554,-0.0814895798380215,-0.0601162726775302,2.50202232184088e-38
CR2,Complement receptor type 2,NMR metabolomics,X23560.Phospholipids in Large HDL,42689,-0.0710625685678428,0.00544863241823932,-0.0817418881075919,-0.0603832490280937,1.20414600958272e-38
CR2,Complement receptor type 2,NMR metabolomics,X23561.Cholesterol in Large HDL,42689,-0.0713592120265044,0.00539220228852045,-0.0819279285120044,-0.0607904955410043,9.89987177015856e-40
CR2,Complement receptor type 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42689,-0.0725172839855889,0.00538076925454484,-0.0830635917244968,-0.061970976246681,3.93441317462288e-41
CR2,Complement receptor type 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42689,-0.0653976463262487,0.00540939772493287,-0.0760000658671171,-0.0547952267853803,1.78439713167203e-33
CR2,Complement receptor type 2,NMR metabolomics,X23564.Triglycerides in Large HDL,42689,-0.00095042941212624,0.00506862947790697,-0.0108849431888239,0.00898408436457142,0.851261948138996
CR2,Complement receptor type 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42689,-0.0800268270702472,0.0050766888685627,-0.0899771372526301,-0.0700765168878643,1.73068063275171e-55
CR2,Complement receptor type 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42689,-0.0771814183543807,0.00503829295463563,-0.0870564725454665,-0.0673063641632948,1.5795687568389e-52
CR2,Complement receptor type 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42689,-0.0719288456571954,0.00501875392849047,-0.0817656033570367,-0.062092087957354,3.01570833099718e-46
CR2,Complement receptor type 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42689,-0.0861017153634664,0.00505519081294859,-0.0960098893568457,-0.0761935413700872,2.22233158965392e-64
CR2,Complement receptor type 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42689,-0.0862320518885647,0.0050287158604507,-0.096088334975048,-0.0763757688020813,3.19304925380139e-65
CR2,Complement receptor type 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42689,-0.0824032709248876,0.00514806407571722,-0.0924934765132933,-0.0723130653364818,3.85180312505758e-57
CR2,Complement receptor type 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42689,0.00923049797571714,0.00491770576332341,-0.000408205320396742,0.018869201271831,0.060540646659758
CR2,Complement receptor type 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42689,-0.0555218890097516,0.00468251519534208,-0.0646996187926221,-0.0463441592268811,2.85279307133072e-32
CR2,Complement receptor type 2,NMR metabolomics,X23573.Total Lipids in Small HDL,42689,-0.0517867963618599,0.00472259769957634,-0.0610430878530295,-0.0425305048706902,7.31993445511928e-28
CR2,Complement receptor type 2,NMR metabolomics,X23574.Phospholipids in Small HDL,42689,-0.0525153696833215,0.00475125996176351,-0.061827839208378,-0.0432029001582651,2.80527015808438e-28
CR2,Complement receptor type 2,NMR metabolomics,X23575.Cholesterol in Small HDL,42689,-0.0609753363096389,0.00467275036076292,-0.0701339270167342,-0.0518167456025436,1.10178527489605e-38
CR2,Complement receptor type 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42689,-0.0596659531004594,0.00465025448670973,-0.0687804518944105,-0.0505514543065084,1.82733409648479e-37
CR2,Complement receptor type 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42689,-0.0563494794895865,0.00479150633516441,-0.0657408319065088,-0.0469581270726643,8.9350531223104e-32
CR2,Complement receptor type 2,NMR metabolomics,X23578.Triglycerides in Small HDL,42689,0.0271293104076561,0.00500134011248915,0.0173266837871774,0.0369319370281349,5.91491381753967e-08
CR2,Complement receptor type 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42197,0.0100291400143681,0.00479451221455715,0.000631896073836053,0.0194263839549001,0.0364761444417815
CR2,Complement receptor type 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42197,-0.0105197761717373,0.00494922934734773,-0.0202202656925389,-0.00081928665093578,0.0335605234136942
CR2,Complement receptor type 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42197,-0.00442791445318262,0.00489569398866387,-0.0140234746709638,0.00516764576459857,0.365773156331882
CR2,Complement receptor type 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42197,-0.0170339448591103,0.00496836985523245,-0.0267719497753659,-0.00729593994285465,0.000608858364767622
CR2,Complement receptor type 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42197,0.00452492080783439,0.00491695045571545,-0.00511230208536789,0.0141621437010367,0.357448880412378
CR2,Complement receptor type 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42568,0.0376706518093491,0.00477555450349935,0.0283105649824904,0.0470307386362078,3.30206150264779e-15
CR2,Complement receptor type 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42568,-0.00794372889664021,0.00501871337933169,-0.0177804071201303,0.0018929493268499,0.11348573423053
CR2,Complement receptor type 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42568,-0.0132805425547862,0.00502376120720943,-0.0231271145209166,-0.00343397058865569,0.00821383705861231
CR2,Complement receptor type 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42568,0.0139698940255253,0.00494830655621045,0.0042712131753528,0.0236685748756978,0.00476220893340443
CR2,Complement receptor type 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42568,-0.00459434504801885,0.00492210653241871,-0.0142416738515595,0.00505298375552182,0.350625003518021
CR2,Complement receptor type 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42688,0.0462314259749705,0.00487810148008724,0.0366703470739995,0.0557925048759415,3.03701025887055e-21
CR2,Complement receptor type 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42688,0.00970693763690875,0.00475392302968278,0.000389248498730507,0.019024626775087,0.0411828959905756
CR2,Complement receptor type 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42688,0.00292979596315487,0.0048908939364453,-0.00665635615227793,0.0125159480785877,0.549162421599171
CR2,Complement receptor type 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42688,0.023088656203943,0.00468954481621418,0.0138971483641632,0.0322801640437227,8.6044995394675e-07
CR2,Complement receptor type 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42688,-0.0260910243186164,0.00467039579446197,-0.0352450000757619,-0.016937048561471,2.36214178007689e-08
CR2,Complement receptor type 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42689,-0.0089416725444287,0.00475156826022923,-0.018254746334478,0.000371401245620601,0.0598797792913301
CR2,Complement receptor type 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42689,-0.0210010014349736,0.00493002003022911,-0.0306638406942227,-0.0113381621757246,2.0597736922213e-05
CR2,Complement receptor type 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42689,-0.0234006766684531,0.00497992663798711,-0.0331613328789078,-0.0136400204579983,2.64019694828133e-06
CR2,Complement receptor type 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42689,-0.0146191554766864,0.00481263330942221,-0.024051916763154,-0.0051863941902189,0.0023887640606539
CR2,Complement receptor type 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42689,0.0182480714522889,0.00488700752443391,0.00866953670439839,0.0278266062001793,0.000189239708505673
CR2,Complement receptor type 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42689,-0.0288942493855123,0.00491302776841659,-0.0385237838116088,-0.0192647149594158,4.17069473746668e-09
CR2,Complement receptor type 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42689,-0.0103449820572079,0.00478960315959617,-0.0197326042500164,-0.000957359864399449,0.0307992877537854
CR2,Complement receptor type 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42689,0.00370277060398968,0.00469727978270185,-0.00550389777010596,0.0129094389780853,0.430546927270279
CR2,Complement receptor type 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42689,-0.029382044857442,0.00493105869182182,-0.0390469198934127,-0.0197171698214712,2.60798936947645e-09
CR2,Complement receptor type 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42689,0.0159237327735764,0.00483205280586071,0.00645290927408942,0.0253945562730634,0.000985216327116024
CR2,Complement receptor type 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42689,0.0471866825876328,0.00479447659182434,0.0377895084676571,0.0565838567076085,8.86536149641963e-23
CR2,Complement receptor type 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42689,-0.0311279161091421,0.00496707220659145,-0.0408633776340613,-0.0213924545842228,3.79618570720165e-10
CR2,Complement receptor type 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42689,-0.0341478302097687,0.00500685259003032,-0.0439612612862282,-0.0243343991333093,9.47723082308997e-12
CR2,Complement receptor type 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42689,-0.0064391895631038,0.00471497087645514,-0.0156805324809559,0.00280215335474828,0.172058979541959
CR2,Complement receptor type 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42689,0.0245094470729888,0.00494821823649616,0.0148109393294564,0.0342079548165213,7.38916982805221e-07
CR2,Complement receptor type 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42689,0.0436671941972918,0.00452083803759203,0.0348063516436114,0.0525280367509721,5.29965579798961e-22
CR2,Complement receptor type 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42689,-0.0452536740716579,0.00478394925012885,-0.0546302146019104,-0.0358771335414053,3.59909294812819e-21
CR2,Complement receptor type 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42689,-0.0491574864466947,0.00477466648934408,-0.0585158327658091,-0.0397991401275803,9.11935318339494e-25
CR2,Complement receptor type 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42689,-0.0146682764629545,0.00461548240016129,-0.0237146219672707,-0.00562193095863841,0.00148598863590395
CR2,Complement receptor type 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42689,0.0381632726812207,0.00493979531952481,0.028481273854952,0.0478452715074893,1.19086489407854e-14
CR2,Complement receptor type 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42689,0.0071929811168219,0.00459797445132604,-0.00181904880777713,0.0162050110414209,0.117751708252904
CR2,Complement receptor type 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42689,-0.0397292521027529,0.00496611506265444,-0.0494628376255556,-0.0299956665799502,1.34438514607621e-15
CR2,Complement receptor type 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42689,-0.0150440201808186,0.00464177398286062,-0.0241418971872254,-0.00594614317441179,0.00119397227264038
CR2,Complement receptor type 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42689,-0.0403833973362547,0.00496969777551535,-0.0501240049762648,-0.0306427896962446,4.82347869798368e-16
CR2,Complement receptor type 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42689,0.0331500160770528,0.00495847942568352,0.0234313964027131,0.0428686357513925,2.39152607873854e-11
CR2,Complement receptor type 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42689,-0.00816115210793121,0.00472306990183937,-0.0174183691155364,0.00109606489967396,0.0840229710949329
CR2,Complement receptor type 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42689,-0.0223237535331713,0.00459588511016382,-0.0313316883490924,-0.0133158187172502,1.20311429844557e-06
CR2,Complement receptor type 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42689,0.0158821227621257,0.00476018533810142,0.00655215949944693,0.0252120860248045,0.000850846315087973
CR2,Complement receptor type 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42689,-0.0416690969939184,0.00507531479506412,-0.0516167139922441,-0.0317214799955928,2.40839845267379e-16
CR2,Complement receptor type 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42689,0.027539281958607,0.00487461485855221,0.0179850368358447,0.0370935270813694,1.64138836035579e-08
CR2,Complement receptor type 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42689,-0.00853881804409647,0.00465888778537315,-0.0176702381034278,0.000592602015234894,0.0668540663901727
CR2,Complement receptor type 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42689,-0.0219126749177776,0.00469368806337203,-0.0311123035219868,-0.0127130463135684,3.0626761063469e-06
CR2,Complement receptor type 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42689,0.0107311822311122,0.00466358710741132,0.00159055150058599,0.0198718129616384,0.021403546560743
CR2,Complement receptor type 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42689,-0.0347980394229593,0.0049767388723184,-0.0445524476127033,-0.0250436312332152,2.83465234392657e-12
CR2,Complement receptor type 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42689,0.0335074787072784,0.00497036096713425,0.0237655712116953,0.0432493862028616,1.63178988908149e-11
CR2,Complement receptor type 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42679,-0.0214999206278911,0.00518724723293061,-0.0316669252044351,-0.0113329160513471,3.42240558904803e-05
CR2,Complement receptor type 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42679,-0.00890105173815565,0.00490491033135386,-0.0185146759876092,0.000712572511297908,0.0695887549087401
CR2,Complement receptor type 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42679,-0.0514628209808932,0.00473528439135672,-0.0607439783879524,-0.042181663573834,2.12809665969447e-27
CR2,Complement receptor type 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42679,0.0568271573210608,0.00540247202767757,0.0462383121468128,0.0674160024953088,8.91153877037084e-26
CR2,Complement receptor type 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42679,0.0418695457309848,0.00515778885388401,0.0317602795773722,0.0519788118845975,5.15910491537901e-16
CR2,Complement receptor type 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42689,0.0192835792935299,0.0050379381552389,0.00940922050926167,0.0291579380777982,0.000129944522832239
CR2,Complement receptor type 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42689,-0.0439527496424919,0.00518927485109919,-0.0541237283506463,-0.0337817709343375,2.70744761790257e-17
CR2,Complement receptor type 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42689,-0.0460399800518468,0.00522047239144491,-0.0562721059390788,-0.0358078541646148,1.29355068320379e-18
CR2,Complement receptor type 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42689,-0.0206789527085653,0.00494201318281989,-0.0303652985468923,-0.0109926068702383,2.87834435360271e-05
CR2,Complement receptor type 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42689,0.0600919157954004,0.00511494023278212,0.0500666329391475,0.0701171986516534,1.02807981283346e-31
CR2,Complement receptor type 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42689,0.0637510828814727,0.00509352477228158,0.0537677743278008,0.0737343914351446,9.6256245272021e-36
CR2,Complement receptor type 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42689,-0.0637543150861919,0.00504739086296473,-0.0736472011776028,-0.053861428994781,2.2836722366026e-36
CR2,Complement receptor type 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42689,-0.0548684517914518,0.00502260290157497,-0.0647127534785387,-0.0450241501043648,1.15171660729661e-27
CR2,Complement receptor type 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42689,-0.0722752499511383,0.0052732321266777,-0.0826107849194266,-0.06193971498285,1.79725903166459e-42
CR2,Complement receptor type 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42689,0.0589747436209807,0.00497994667250169,0.0492140481428774,0.068735439099084,3.39903965238788e-32
CR2,Complement receptor type 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42689,-0.00908658402056353,0.00490455864315645,-0.0186995189611502,0.000526350920023112,0.0639498715863982
CR2,Complement receptor type 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42689,-0.0322216962679904,0.00489124176341102,-0.0418085301242759,-0.0226348624117048,4.63467933993067e-11
CR2,Complement receptor type 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42689,-0.0297844159979195,0.0049384072766576,-0.0394636942601684,-0.0201051377356706,1.67022068201939e-09
CR2,Complement receptor type 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42689,-0.0165041514573856,0.0048885496759619,-0.026085708822271,-0.00692259409250032,0.000737330280231173
CR2,Complement receptor type 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42689,0.0603365985541195,0.00502830593393689,0.0504811189236032,0.0701920781846358,5.26882811154844e-33
CR2,Complement receptor type 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52196,4.94397168271155e-06,0.00405705559243765,-0.00794688498949509,0.00795677293286051,0.999027700080753
CR2,Complement receptor type 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52196,0.000610193923412638,0.00394599542740089,-0.0071239571142931,0.00834434496111837,0.877109449482822
CR2,Complement receptor type 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50730,1.50883835770109e-05,0.00374810046443896,-0.00733118852672336,0.00736136529387738,0.996788075413177
CR2,Complement receptor type 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50730,0.00288190566083093,0.00412093651202106,-0.00519512990273035,0.0109589412243922,0.484351688181573
CR2,Complement receptor type 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50730,0.00164980844837978,0.00401976322426462,-0.00622892747117888,0.00952854436793843,0.681498817464411
CR2,Complement receptor type 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50730,-0.00506734995432118,0.00366427444796334,-0.0122493278723293,0.00211462796368697,0.166707790814846
CR2,Complement receptor type 2,Working and living environment,X24009.Traffic intensity on the nearest road,52196,-0.0751078785565885,0.0510897512316903,-0.175243790970702,0.0250280338575245,0.141543923407201
CR2,Complement receptor type 2,Working and living environment,X24010.Inverse distance to the nearest road,52196,-0.000441078707197986,0.00353863669064669,-0.00737680662086551,0.00649464920646953,0.900804496503752
CR2,Complement receptor type 2,Working and living environment,X24011.Traffic intensity on the nearest major road,52196,-0.000262829066948933,0.00349445377374647,-0.00711195846349202,0.00658630032959416,0.940045732369932
CR2,Complement receptor type 2,Working and living environment,X24012.Inverse distance to the nearest major road,52196,0.00116355115954712,0.00356390145939333,-0.00582169570086381,0.00814879801995805,0.744062361340901
CR2,Complement receptor type 2,Working and living environment,X24013.Total traffic load on major roads,52196,-0.0452690436404286,0.0357028213730841,-0.115246573531673,0.0247084862508161,0.204832129526512
CR2,Complement receptor type 2,Working and living environment,X24015.Sum of road length of major roads within 100m,52196,-0.0546706350622595,0.0347103442554647,-0.12270290980297,0.0133616396784514,0.115257943375073
CR2,Complement receptor type 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52196,0.00315372059535934,0.00402759394608531,-0.00474036353896787,0.0110478047296865,0.433618474248356
CR2,Complement receptor type 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52196,0.00335652213260627,0.00401837217296327,-0.00451948732640175,0.0112325315916143,0.403560875235248
CR2,Complement receptor type 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52196,0.003485278915406,0.0039744472254236,-0.00430463764642426,0.0112751954772363,0.38053834096747
CR2,Complement receptor type 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52142,0.00251377731402932,0.00396389151876491,-0.00525545006274991,0.0102830046908086,0.525976825713835
CR2,Complement receptor type 2,Working and living environment,X24020.Average daytime sound level of noise pollution,52196,-0.00177167879161079,0.00355942807069605,-0.00874815781017504,0.00520480022695346,0.618670274030754
CR2,Complement receptor type 2,Working and living environment,X24021.Average evening sound level of noise pollution,52196,-0.00173223490653135,0.00356018248825913,-0.00871019258351925,0.00524572277045655,0.626576301792673
CR2,Complement receptor type 2,Working and living environment,X24022.Average night-time sound level of noise pollution,52196,-0.00176586885321534,0.00355941657219098,-0.00874232533470967,0.00521058762827899,0.619820217070093
CR2,Complement receptor type 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52196,-0.00175401057380306,0.00355964425865721,-0.00873091332077118,0.00522289217316506,0.6221947680118
CR2,Complement receptor type 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52196,-0.00176219508224377,0.00355957942592495,-0.00873897075705667,0.00521458059256912,0.620564540965872
CR2,Complement receptor type 2,Health and medical history,X2405.Number of children fathered,40160,-0.0491263705942191,0.0397934232748729,-0.12712148021297,0.0288687390245319,0.217030096219863
CR2,Complement receptor type 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49892,-0.0020860167109801,0.00411002898743342,-0.0101416735263496,0.00596964010438941,0.611779235311566
CR2,Complement receptor type 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49892,0.00752145663730607,0.0036903218205606,0.000288425869007286,0.0147544874056049,0.0415468821135615
CR2,Complement receptor type 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49892,0.00128089432283419,0.00374772169957004,-0.00606464020832309,0.00862642885399147,0.732520333294821
CR2,Complement receptor type 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49892,-0.00237639525814362,0.00385239645606862,-0.00992709231203812,0.00517430179575088,0.537332833393779
CR2,Complement receptor type 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49892,0.00544530650418168,0.00370842707600088,-0.00182321056478005,0.0127138235731434,0.142021618986135
CR2,Complement receptor type 2,Working and living environment,"X24505.Water percentage, buffer 300m",49892,0.00135514284001974,0.00377630445969086,-0.00604641390097436,0.00875669958101383,0.719707799318154
CR2,Complement receptor type 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52340,-0.00257484783113258,0.00397268709573737,-0.0103613145387778,0.00521161887651266,0.516902394002572
CR2,Complement receptor type 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52340,-0.00318780876698549,0.00371489371000415,-0.0104690004385936,0.00409338290462265,0.390837442095285
CR2,Complement receptor type 2,Working and living environment,X24508.Distance (Euclidean) to coast,52340,0.00356645497374546,0.00350301404244714,-0.00329945254945092,0.0104323624969418,0.308636142389766
CR2,Complement receptor type 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35580,-0.0453773463536484,0.0482876056737313,-0.140021053474162,0.049266360766865,0.347391246903823
CR2,Complement receptor type 2,Health and medical history,X2704.Years since last cervical smear test,38501,0.107223457660117,0.0414428845477935,0.0259954039464421,0.188451511373793,0.00968931556631736
CR2,Complement receptor type 2,Health and medical history,X2714.Age when periods started (menarche),40958,-0.00575642692703966,0.0328195202497769,-0.0700826866166023,0.058569832762523,0.860771158486244
CR2,Complement receptor type 2,Health and medical history,X2734.Number of live births,41315,-0.0314953031230622,0.031473648912675,-0.0931836549919051,0.0301930487457808,0.316997653252884
CR2,Complement receptor type 2,Health and medical history,X2744.Birth weight of first child,39462,-0.0500127164762494,0.0337702019374039,-0.116202312273561,0.0161768793210623,0.138644797830468
CR2,Complement receptor type 2,Health and medical history,X2754.Age at first live birth,38224,0.0111201916064433,0.00638768685877268,-0.00139967463675112,0.0236400578496378,0.0817387996414706
CR2,Complement receptor type 2,Health and medical history,X2764.Age at last live birth,38193,0.00250891212214106,0.00585138877229239,-0.00895980987155201,0.0139776341158341,0.668099362766667
CR2,Complement receptor type 2,Health and medical history,X2794.Age started oral contraceptive pill,37128,0.0145773855091603,0.00919931542199095,-0.00345327271794194,0.0326080437362626,0.113093380237909
CR2,Complement receptor type 2,Health and medical history,X2804.Age when last used oral contraceptive pill,36334,-0.0186209206920955,0.0069156382550726,-0.0321755716720377,-0.00506626971215316,0.00710666163500912
CR2,Complement receptor type 2,Lifestyle factors,X2867.Age started smoking in former smokers,36285,-0.0052179372786178,0.00674409373937162,-0.0184363610077862,0.00800048645055058,0.439131206369202
CR2,Complement receptor type 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36100,0.0603309936261843,0.0544064749108876,-0.0463056971991554,0.166967684451524,0.267514696332656
CR2,Complement receptor type 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36097,-0.00819228457101313,0.0595917084268608,-0.12499203308766,0.108607463945634,0.890660497397976
CR2,Complement receptor type 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36112,0.0710601034127873,0.0622693014670222,-0.0509877274625762,0.193107934288151,0.253837063488539
CR2,Complement receptor type 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36086,0.108789755317777,0.0610073553967352,-0.0107846612598245,0.228364171895378,0.0745939218685073
CR2,Complement receptor type 2,Mental health,X28739.Difficulty with standing for long periods,36118,0.00503184103448861,0.0463217075605901,-0.0857587057842679,0.0958223878532452,0.913500587646759
CR2,Complement receptor type 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36140,0.0270842237791776,0.0516553689094559,-0.074160299283356,0.128328746841711,0.600068947067173
CR2,Complement receptor type 2,Mental health,X28741.Difficulty learning a new task,36081,0.0259361623460109,0.0591745035734944,-0.0900458646580382,0.14191818935006,0.66118285549331
CR2,Complement receptor type 2,Mental health,X28742.Difficulty with joining in community activities,35811,0.0820636661500845,0.0636524456042019,-0.0426951272341512,0.20682245953432,0.197357634211637
CR2,Complement receptor type 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36096,0.0880343930280473,0.0534800524599176,-0.0167865097933912,0.192855295849486,0.0997853399180142
CR2,Complement receptor type 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36142,-0.0685321497611835,0.0817369214149403,-0.228736515734467,0.0916722162120995,0.401808054990987
CR2,Complement receptor type 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35796,0.100808627361616,0.0457327672504679,0.011172403550699,0.190444851172533,0.0275378007411486
CR2,Complement receptor type 2,Lifestyle factors,X2897.Age stopped smoking,36284,0.0146265883846794,0.00635722040836828,0.0021664363842776,0.0270867403850813,0.0214327430712188
CR2,Complement receptor type 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35409,-0.0015557168383988,0.0149188376212427,-0.0307966385760345,0.0276852048992369,0.916951553708003
CR2,Complement receptor type 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35409,0.0187545711681884,0.0167550262001138,-0.0140852801840345,0.0515944225204114,0.263038371077384
CR2,Complement receptor type 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35409,0.00527062644035973,0.055315187560566,-0.10314714117835,0.113688394059069,0.924092694610779
CR2,Complement receptor type 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35409,-0.0196194761106247,0.0635287934248291,-0.14413591122329,0.10489695900204,0.757462649454457
CR2,Complement receptor type 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35409,-0.032314121783439,0.0782107152292077,-0.185607123632686,0.120978880065808,0.679498188191323
CR2,Complement receptor type 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35409,0.017943727945458,0.0654753196293706,-0.110387898528108,0.146275354419024,0.784052762916849
CR2,Complement receptor type 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35409,-0.00407889320669822,0.027360114231179,-0.057704717099809,0.0495469306864125,0.881493977840502
CR2,Complement receptor type 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35409,0.0232099230358478,0.0466124114574371,-0.0681504034207288,0.114570249492424,0.618547899387967
CR2,Complement receptor type 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35364,-0.0334696136068357,0.0639884931192911,-0.158887060120646,0.0919478329069749,0.600953546429543
CR2,Complement receptor type 2,Mental health,X29003.Recent feelings of depression,35352,0.0151240232485492,0.0619803557944264,-0.106357474108526,0.136605520605625,0.807228749643897
CR2,Complement receptor type 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35366,-0.0187767044923558,0.0482500282169672,-0.113346759797611,0.0757933508128999,0.69717545944466
CR2,Complement receptor type 2,Mental health,X29005.Recent feelings of tiredness or low energy,35369,0.0156137418520174,0.0474089220457553,-0.0773077453576629,0.108535229061698,0.741908492494353
CR2,Complement receptor type 2,Mental health,X29006.Recent poor appetite or overeating,35379,-0.0311280935525148,0.0737905534366443,-0.175757578288338,0.113501391183308,0.673153638899319
CR2,Complement receptor type 2,Mental health,X29007.Recent feelings of inadequacy,35346,0.0572984726190556,0.0698739634166693,-0.0796544956776162,0.194251440915727,0.412233017039118
CR2,Complement receptor type 2,Mental health,X29008.Recent trouble concentrating on things,35377,-0.00422947650758635,0.0676208062808373,-0.136766256818027,0.128307303802855,0.950129281277254
CR2,Complement receptor type 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35370,0.215678811107681,0.115380917692976,-0.0104677875705514,0.441825409785913,0.0616316923239021
CR2,Complement receptor type 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35349,0.181901373933464,0.130496188624361,-0.0738711557702834,0.437673903637211,0.163391807718118
CR2,Complement receptor type 2,Mental health,X29038#0.Substances taken for depression_None of options listed,36410,0.0379315588252851,0.0297036866350042,-0.0202876669793231,0.0961507846298934,0.201643918781585
CR2,Complement receptor type 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36410,0.00804373660827103,0.0777434138811295,-0.144333354598743,0.160420827815285,0.917596655656566
CR2,Complement receptor type 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36410,0.0301489476681789,0.030709993465767,-0.0300426395247244,0.0903405348610823,0.326265381346541
CR2,Complement receptor type 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36410,-0.0840808285151176,0.0949820337112591,-0.270245614589185,0.10208395755895,0.376062756693889
CR2,Complement receptor type 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36410,-0.0603668660100482,0.0793554263498567,-0.215903501655767,0.095169769635671,0.446852147863524
CR2,Complement receptor type 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36410,-0.126472176131275,0.0829689439267297,-0.289091306227666,0.036146953965115,0.127469740606337
CR2,Complement receptor type 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36410,0.109965880993126,0.0850356746475859,-0.0567040413161422,0.276635803302395,0.195992456398054
CR2,Complement receptor type 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36410,-0.0786236460396885,0.0850613795023368,-0.245343949864269,0.0880966577848916,0.355352404056493
CR2,Complement receptor type 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36410,0.0717650872418774,0.0545960784156158,-0.0352432264527295,0.178773400936484,0.188728755785157
CR2,Complement receptor type 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36410,0.0276771437259853,0.0273329650119232,-0.0258954676973841,0.0812497551493547,0.311288998224433
CR2,Complement receptor type 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36410,-0.0642328106480776,0.049031141699434,-0.160333848378968,0.0318682270828131,0.190223634141831
CR2,Complement receptor type 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36410,-0.138223809338603,0.0761373849560152,-0.287453083852392,0.0110054651751871,0.0694958817408713
CR2,Complement receptor type 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36410,-0.0329111769333311,0.10734840687865,-0.243314054415486,0.177491700548823,0.75916978018262
CR2,Complement receptor type 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36410,-0.0454369126330762,0.0732678675306286,-0.189041932993108,0.0981681077269558,0.535180015609886
CR2,Complement receptor type 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36410,-0.0867263959144978,0.10150038736902,-0.285667155157777,0.112214363328781,0.39288739626609
CR2,Complement receptor type 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36410,-0.208579540516568,0.103396138405936,-0.411235971792202,-0.005923109240934,0.0437026731616816
CR2,Complement receptor type 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36410,-0.00558758213858312,0.0600033255556578,-0.123194100227672,0.112018935950506,0.925809854557802
CR2,Complement receptor type 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36410,-0.0208539017514314,0.0557119793152781,-0.130049381209377,0.0883415777065136,0.708180007862051
CR2,Complement receptor type 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36410,0.0939606916704009,0.0776152366443162,-0.0581651721524588,0.246086555493261,0.226089944351324
CR2,Complement receptor type 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35274,0.0511573899003184,0.0570928241867459,-0.0607445455057037,0.16305932530634,0.370267487241619
CR2,Complement receptor type 2,Mental health,X29059.Recent inability to stop or control worrying,35287,0.0338124909959958,0.0584367771817373,-0.0807235922802092,0.148348574272201,0.562869275751751
CR2,Complement receptor type 2,Mental health,X29060.Recent worrying too much about different things,35285,0.0223466226483729,0.0542166965345033,-0.0839181025592535,0.128611347855999,0.680227619301682
CR2,Complement receptor type 2,Mental health,X29061.Recent trouble relaxing,35281,0.0463863008696729,0.0586991645239433,-0.0686640615972559,0.161436663336602,0.429419676601248
CR2,Complement receptor type 2,Mental health,X29062.Recent restlessness,35298,-0.0131145287469784,0.0860458140338728,-0.181764324253369,0.155535266759412,0.878865985930669
CR2,Complement receptor type 2,Mental health,X29063.Recent easy annoyance or irritability,35268,-0.116341354066906,0.059697928919572,-0.233349294749268,0.00066658661545492,0.0513612438451561
CR2,Complement receptor type 2,Mental health,X29064.Recent feelings of foreboding,35269,-0.0230497598346331,0.0675235362417108,-0.155395890868386,0.10929637119912,0.732845224211185
CR2,Complement receptor type 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36410,0.0509150254313497,0.0344082798440993,-0.0165252030630849,0.118355253925784,0.138988492966463
CR2,Complement receptor type 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36410,0.0214015182247014,0.061121122839991,-0.0983958825416809,0.141198918991084,0.726236875243653
CR2,Complement receptor type 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36410,0.042947213251892,0.0769379769605942,-0.107851221590873,0.193745648094657,0.576721283154131
CR2,Complement receptor type 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36410,0.0121977412000845,0.0695103572376863,-0.124042558985781,0.14843804138595,0.860706688166937
CR2,Complement receptor type 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36410,0.0470286560585594,0.0528264922779415,-0.0565112688062058,0.150568580923325,0.373362649261832
CR2,Complement receptor type 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36410,0.0744263088477988,0.0563577904542774,-0.036034960442585,0.184887578138183,0.186675406479291
CR2,Complement receptor type 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36410,0.0486653896390478,0.0560576561094459,-0.0612076163354662,0.158538395613562,0.385351486351598
CR2,Complement receptor type 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36410,0.0317494259517366,0.0563623952425323,-0.0787208687236267,0.1422197206271,0.573242217488947
CR2,Complement receptor type 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36410,0.036285467140711,0.0726841305806184,-0.106175428797301,0.178746363078723,0.617638700271093
CR2,Complement receptor type 2,Mental health,X29076.Felt loved as a child,35266,-0.0250310526776789,0.049779068267228,-0.122598026481446,0.0725359211260879,0.615092952532533
CR2,Complement receptor type 2,Mental health,X29077.Physically abused by family as a child,35287,0.0485259519656285,0.0734373382071369,-0.0954112309203597,0.192463134851617,0.508778163585064
CR2,Complement receptor type 2,Mental health,X29078.Felt hated by family member as a child,35272,0.00177483846915358,0.073099522813781,-0.141500226245857,0.145049903184164,0.980630259364865
CR2,Complement receptor type 2,Mental health,X29079.Sexually molested as a child,35228,-0.305759630625503,0.0913950031118358,-0.484893836724702,-0.126625424526305,0.00082643723553993
CR2,Complement receptor type 2,Mental health,X29080.Someone to take to doctor when needed as a child,35247,-0.0482492516129468,0.0688032234491333,-0.183103569573248,0.0866050663473545,0.483164994298317
CR2,Complement receptor type 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35278,-0.0101021263820451,0.106880678518541,-0.219588256278386,0.199384003514296,0.924700958052544
CR2,Complement receptor type 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35232,-0.133335170758197,0.0807327907350182,-0.291571440598832,0.0249010990824388,0.0986759785923448
CR2,Complement receptor type 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35284,-0.165784120273113,0.0935055146027489,-0.349054928894501,0.0174866883482749,0.0762807390613629
CR2,Complement receptor type 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35271,-0.063587223909722,0.130047221738893,-0.318479778517952,0.191305330698508,0.624891288049688
CR2,Complement receptor type 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35272,-0.209641458467286,0.119196729283251,-0.443267047862458,0.0239841309278861,0.0786643019815277
CR2,Complement receptor type 2,Mental health,X29086.Experienced a violent or sexual assault,35286,-0.139274972626783,0.113297475311716,-0.361338024237747,0.0827880789841812,0.219012170738269
CR2,Complement receptor type 2,Mental health,X29087.Experienced a life-threatening injury or illness,35281,-0.0162667449331587,0.0548496571331889,-0.123772072914209,0.0912385830478915,0.766805186319406
CR2,Complement receptor type 2,Mental health,X29088.Experienced a marital separation or divorce,35286,-0.0725193240785387,0.0556326256420364,-0.18155927033693,0.0365206221798526,0.192439912704163
CR2,Complement receptor type 2,Mental health,X29089.Experienced the death of a spouse or partner,35293,-0.0515148094318877,0.0602838173319327,-0.169671091402476,0.0666414725387005,0.392840563241502
CR2,Complement receptor type 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35284,0.0716403628296268,0.0712765871420991,-0.0680617479688875,0.211342473628141,0.314886849045931
CR2,Complement receptor type 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35283,-0.253974698940618,0.044562150803226,-0.341316514514941,-0.166632883366295,1.25913277555127e-08
CR2,Complement receptor type 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34525,-0.248134599536109,0.0552522712907869,-0.356429051266052,-0.139840147806167,7.24069265758504e-06
CR2,Complement receptor type 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34549,-0.231629556675757,0.056821652941405,-0.342999996440911,-0.120259116910603,4.63950697135932e-05
CR2,Complement receptor type 2,Mental health,X29104.Ever used cannabis,35284,-0.108824807523465,0.0830920535419822,-0.27168523246575,0.0540356174188203,0.190350253884869
CR2,Complement receptor type 2,Mental health,X29108.Ever thought that life not worth living,35249,-0.025593504207867,0.0616850533441798,-0.146496208762459,0.0953092003467254,0.678225354538391
CR2,Complement receptor type 2,Mental health,X29109.Ever contemplated self-harm,35275,0.0375578252887729,0.0926511981576604,-0.144038523100241,0.219154173677787,0.685221336556185
CR2,Complement receptor type 2,Mental health,X29111.Ever self-harmed,35283,0.148498236168625,0.163534823220882,-0.172030017344304,0.469026489681553,0.363886326600798
CR2,Complement receptor type 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35272,-0.034028679418367,0.0917899523262236,-0.213936985977765,0.145879627141031,0.710856511981873
CR2,Complement receptor type 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,37029,-0.0209930369509124,0.0805043562203376,-0.178781575142774,0.136795501240949,0.794277538839879
CR2,Complement receptor type 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,37029,0.0216404319345515,0.0601613809704464,-0.0962758747675235,0.139556738636626,0.719076422833463
CR2,Complement receptor type 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,37029,-0.00360663796456446,0.0710011720102023,-0.142768935104561,0.135555659175432,0.959488672510217
CR2,Complement receptor type 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,37029,-0.0465479464814974,0.103839390657204,-0.250073152169617,0.156977259206622,0.653971697533949
CR2,Complement receptor type 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35263,-0.0242533140277755,0.0517351479682839,-0.125654204045612,0.077147575990061,0.639231145090274
CR2,Complement receptor type 2,Health and medical history,X29153.Pain or discomfort today,35274,0.0550160585384017,0.0469884846372001,-0.0370813713505105,0.147113488427314,0.241708481575888
CR2,Complement receptor type 2,Mental health,X29154.Anxiety or depression today,35274,0.0287312636288746,0.0612243171579939,-0.0912683980007934,0.148730925258543,0.638887324366936
CR2,Complement receptor type 2,Mental health,X29166.Frequency of confiding in someone close,35090,-0.0380953098864824,0.0462889277784154,-0.128821608332177,0.0526309885592118,0.410547168621497
CR2,Complement receptor type 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35257,0.0188961746198588,0.0145326460328043,-0.00958781160443765,0.0473801608441553,0.193562327224816
CR2,Complement receptor type 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35257,-0.00529078513307494,0.014880467269019,-0.0344565009803522,0.0238749307142023,0.722188201431302
CR2,Complement receptor type 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35257,-0.0156857157286529,0.0185520300338822,-0.052047694595062,0.0206762631377561,0.397865869561102
CR2,Complement receptor type 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35257,0.0110338390995099,0.0172144367610972,-0.0227064569522405,0.0447741351512604,0.521570115273022
CR2,Complement receptor type 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35257,-0.0314502944579982,0.0295052118473769,-0.0892805096788568,0.0263799207628605,0.286500733885397
CR2,Complement receptor type 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35257,-0.0070654792875345,0.0140604574755417,-0.0346239759395963,0.0204930173645273,0.615329130944273
CR2,Complement receptor type 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35255,0.0142978554237771,0.0150969191452513,-0.0152921061009154,0.0438878169484696,0.343640319497321
CR2,Complement receptor type 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35255,-0.0369353215492435,0.0233116792441578,-0.0826262128677928,0.00875556976930582,0.113151995743431
CR2,Complement receptor type 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35255,-0.0440551916521747,0.0336459227104337,-0.110001200164625,0.0218908168602753,0.190456369159078
CR2,Complement receptor type 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35255,0.00940678130919715,0.0270136569111119,-0.0435399862365822,0.0623535488549765,0.727684680120481
CR2,Complement receptor type 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35255,-0.0248116601428733,0.0453276342238197,-0.11365382322156,0.0640305029358134,0.584134517683089
CR2,Complement receptor type 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35255,-0.00247800589891183,0.0204655122383263,-0.0425904098860313,0.0376343980882077,0.903630071004657
CR2,Complement receptor type 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35151,-0.0721062745315837,0.059565697538297,-0.188855041706646,0.0446424926434784,0.226122265491843
CR2,Complement receptor type 2,Mental health,X29172.Freuency of feeling that lacks companionship,35235,0.14244164199479,0.0539628164094475,0.0366745218322733,0.248208762157307,0.00832108967835543
CR2,Complement receptor type 2,Mental health,X29173.Frequency of feeling left out,35192,0.0470617758343634,0.0572655710639455,-0.0651787434509697,0.159302295119696,0.411214165001086
CR2,Complement receptor type 2,Mental health,X29174.Frequency of feeling isolated from others,35227,0.039589034166663,0.0592322270306513,-0.0765061308134136,0.15568419914674,0.503923116062676
CR2,Complement receptor type 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35269,0.013647768124506,0.047278954290806,-0.0790189822854737,0.106314518534486,0.772847784153208
CR2,Complement receptor type 2,Mental health,X29176.Ability to make it through stressful events,35269,0.0554020545132905,0.0452684018954136,-0.0333240132017201,0.144128122228301,0.221053630967879
CR2,Complement receptor type 2,Mental health,X29177.Quick recovery from stressful events,35269,-0.00553196444770716,0.0466228262593375,-0.0969127039160087,0.0858487750205944,0.905553752952017
CR2,Complement receptor type 2,Mental health,X29178.Hard to snap back when something bad happens,35269,0.0883140780807529,0.0453982685536077,-0.000666528284318124,0.177294684445824,0.0517827861438761
CR2,Complement receptor type 2,Mental health,X29179.Comes through difficult times with little trouble,35269,-0.0426871376323302,0.0464300306656779,-0.133689997737059,0.0483157224723986,0.357930033714893
CR2,Complement receptor type 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35269,0.0363146319346751,0.0455587494623871,-0.0529805170116036,0.125609780880954,0.425427274789622
CR2,Complement receptor type 2,Mental health,X29181.General happiness,35240,-0.00310057067881741,0.047540877435712,-0.0962806904528129,0.0900795490951781,0.948001754456141
CR2,Complement receptor type 2,Mental health,X29182.Belief that own life is meaningful,35146,0.018157373741539,0.047677099168169,-0.0752897406280723,0.11160448811115,0.703335150003355
CR2,Complement receptor type 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35614,0.0242623171492709,0.0427051324304411,-0.0594397424143937,0.107964376712936,0.569962588872445
CR2,Complement receptor type 2,Health and medical history,X2946.Father's age,30175,-0.00216351894847002,0.0347396143816806,-0.0702531631365639,0.0659261252396239,0.950354013869914
CR2,Complement receptor type 2,Health and medical history,X2966.Age high blood pressure diagnosed,36859,-0.0137040568495556,0.00679309789673338,-0.027018528727153,-0.000389584971958163,0.0436937773508758
CR2,Complement receptor type 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51731,0.00551970656905084,0.00385067937519658,-0.00202762500633446,0.0130670381444362,0.151746842722511
CR2,Complement receptor type 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51732,0.0604887530351361,0.0040302216334498,0.0525895186335744,0.0683879874366977,1.13048329320699e-50
CR2,Complement receptor type 2,Blood and urine assays,X30020.Haemoglobin concentration,51732,0.0352114238530632,0.00434260107758474,0.0266999257409971,0.0437229219651293,5.38951925727005e-16
CR2,Complement receptor type 2,Blood and urine assays,X30030.Haematocrit percentage,51732,0.032424478784118,0.00422503840183229,0.0241434035165267,0.0407055540517093,1.72975948257906e-14
CR2,Complement receptor type 2,Blood and urine assays,X30040.Mean corpuscular volume,51732,-0.0551284657676572,0.00370320158964706,-0.0623867408833654,-0.0478701906519489,6.94254691881243e-50
CR2,Complement receptor type 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51732,-0.0466695350410991,0.00371750480517071,-0.0539558444592337,-0.0393832256229645,4.98937974293361e-36
CR2,Complement receptor type 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51732,0.00454083910278584,0.00364953285774938,-0.00261224529840293,0.0116939235039746,0.213429796886048
CR2,Complement receptor type 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51732,-0.000501498480478527,0.00376945497945821,-0.00788963024021662,0.00688663327925956,0.894160796069221
CR2,Complement receptor type 2,Blood and urine assays,X30080.Platelet count,51732,-0.0508951130767317,0.00367496428410883,-0.058098043073585,-0.0436921830798784,1.93976638803955e-43
CR2,Complement receptor type 2,Blood and urine assays,X30090.Platelet crit,51732,-0.0492800146555103,0.00373930240312533,-0.0566090473656359,-0.0419509819453846,1.62471289100362e-39
CR2,Complement receptor type 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51732,0.0162130863043209,0.00351711865109626,0.00931953374817228,0.0231066388604696,4.05337380930671e-06
CR2,Complement receptor type 2,Blood and urine assays,X30110.Platelet distribution width,51732,0.0396846974742142,0.00364437919729085,0.0325417142475242,0.0468276807009043,1.51845114008895e-27
CR2,Complement receptor type 2,Blood and urine assays,X30120.Lymphocyte count,51693,0.00387077150506288,0.0036239349519055,-0.00323214100067189,0.0109736840107977,0.285481068151286
CR2,Complement receptor type 2,Blood and urine assays,X30130.Monocyte count,51693,-0.00305767678553906,0.00370882412794363,-0.0103269720763086,0.00421161850523046,0.409702343699868
CR2,Complement receptor type 2,Blood and urine assays,X30140.Neutrophill count,51693,0.000385091041615915,0.00381937859743938,-0.00710089100936526,0.00787107309259709,0.9196898231127
CR2,Complement receptor type 2,Blood and urine assays,X30150.Eosinophill count,51693,0.0283409010559026,0.00363114858388153,0.0212238498314948,0.0354579522803104,6.21139519933462e-15
CR2,Complement receptor type 2,Blood and urine assays,X30160.Basophill count,51693,-0.0330771393482449,0.0256080912985019,-0.0832689982933086,0.0171147195968189,0.196485585206802
CR2,Complement receptor type 2,Blood and urine assays,X30170.Nucleated red blood cell count,51693,-0.0811427243659019,0.127406192493891,-0.330858861653928,0.168573412922124,0.524208118413497
CR2,Complement receptor type 2,Blood and urine assays,X30180.Lymphocyte percentage,51694,0.00134087575756023,0.0036187682340034,-0.00575190998108642,0.00843366149620689,0.7109883237548
CR2,Complement receptor type 2,Blood and urine assays,X30190.Monocyte percentage,51694,-0.00773406830492449,0.00366331689223293,-0.014914169413701,-0.000553967196147945,0.0347643954627714
CR2,Complement receptor type 2,Blood and urine assays,X30200.Neutrophill percentage,51694,-0.00421208997592893,0.00359170126536567,-0.0112518244560457,0.00282764450418779,0.240917165755225
CR2,Complement receptor type 2,Blood and urine assays,X30210.Eosinophill percentage,51694,0.0266474254541524,0.00360591107433472,0.0195798397484564,0.0337150111598485,1.52031919880166e-13
CR2,Complement receptor type 2,Blood and urine assays,X30220.Basophill percentage,51694,-0.0125593019888819,0.0036015579293575,-0.0196183555304226,-0.00550024844734123,0.000489063260396698
CR2,Complement receptor type 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51693,-0.0799394844762614,0.127430252739153,-0.329702779845002,0.169823810892479,0.530456179398484
CR2,Complement receptor type 2,Blood and urine assays,X30240.Reticulocyte percentage,51349,0.0209097885756176,0.00389441431254405,0.0132767365230313,0.028542840628204,7.98938462183097e-08
CR2,Complement receptor type 2,Blood and urine assays,X30250.Reticulocyte count,51349,0.0340640632280458,0.00395853678461971,0.0263053311301912,0.0418227953259005,8.11587383997603e-18
CR2,Complement receptor type 2,Blood and urine assays,X30260.Mean reticulocyte volume,51349,-0.0315890887974564,0.00363918525494762,-0.0387218918971537,-0.0244562856977591,4.21623768342893e-18
CR2,Complement receptor type 2,Blood and urine assays,X30270.Mean sphered cell volume,51349,-0.0587615584054961,0.00367397666596827,-0.0659625526707939,-0.0515605641401983,2.94486608146127e-57
CR2,Complement receptor type 2,Blood and urine assays,X30280.Immature reticulocyte fraction,51349,-0.00785158227921594,0.00384363239289065,-0.0153851017692816,-0.000318062789150261,0.0410889453976217
CR2,Complement receptor type 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51349,0.0133742839355654,0.00397042059787647,0.00559225956372752,0.0211563083074033,0.00075712515411338
CR2,Complement receptor type 2,Blood and urine assays,X30300.High light scatter reticulocyte count,51349,0.0239154826655802,0.00402095952743122,0.0160344019918151,0.0317965633393454,2.76007992691793e-09
CR2,Complement receptor type 2,Blood and urine assays,X30500.Microalbumin in urine,37208,0.0265428720204055,0.00621247220488427,0.0143664264988323,0.0387193175419787,1.95516417172004e-05
CR2,Complement receptor type 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51717,-0.011701165338698,0.00401587215139282,-0.0195722747554279,-0.0038300559219681,0.0035749034471834
CR2,Complement receptor type 2,Blood and urine assays,X30520.Potassium in urine,51679,-0.00854794028692351,0.00376690022471584,-0.0159310647273666,-0.00116481584648047,0.0232641400368006
CR2,Complement receptor type 2,Blood and urine assays,X30530.Sodium in urine,51659,-0.00411624677685848,0.00396871883634272,-0.0118949356960902,0.00366244214237325,0.299666548437473
CR2,Complement receptor type 2,Blood and urine assays,X30600.Albumin,49481,0.0291835652078888,0.00388439993761751,0.0215701413301585,0.0367969890856191,6.01719742971402e-14
CR2,Complement receptor type 2,Blood and urine assays,X30610.Alkaline phosphatase,51321,0.0734212237052155,0.00380282318785456,0.0659676902570205,0.0808747571534104,2.23265920078218e-82
CR2,Complement receptor type 2,Blood and urine assays,X30620.Alanine aminotransferase,51324,0.0393970325217922,0.00407807272093894,0.0314040099887519,0.0473900550548325,4.8951211589838e-22
CR2,Complement receptor type 2,Blood and urine assays,X30630.Apolipoprotein A,49335,-0.0862235005168839,0.00422728218832881,-0.0945089736060084,-0.0779380274277594,1.49805020312207e-91
CR2,Complement receptor type 2,Blood and urine assays,X30640.Apolipoprotein B,51222,-0.00915517455519681,0.00356115963111668,-0.0161350474321855,-0.00217530167820811,0.0101516988772841
CR2,Complement receptor type 2,Blood and urine assays,X30650.Aspartate aminotransferase,51257,0.0405667180112048,0.00389087744696239,0.0329405982151586,0.0481928378072511,2.15877338945664e-25
CR2,Complement receptor type 2,Blood and urine assays,X30660.Direct bilirubin,48084,0.0126882232417188,0.00413691451518578,0.00457987079195472,0.020796575691483,0.00216470897629256
CR2,Complement receptor type 2,Blood and urine assays,X30670.Urea,51308,0.0316591378688358,0.00375790054391693,0.0242936528027587,0.039024622934913,3.83474904230642e-17
CR2,Complement receptor type 2,Blood and urine assays,X30680.Calcium,49483,0.014993684324076,0.00376626169091414,0.00761181140988424,0.0223755572382677,6.88497758815949e-05
CR2,Complement receptor type 2,Blood and urine assays,X30690.Cholesterol,51328,-0.0266955381494685,0.00359338626590305,-0.0337385752306385,-0.0196525010682985,1.13320650325828e-13
CR2,Complement receptor type 2,Blood and urine assays,X30700.Creatinine,51319,0.042032871785288,0.00417202372894622,0.0338557052765534,0.0502100382940225,8.02655781253085e-24
CR2,Complement receptor type 2,Blood and urine assays,X30710.C-reactive protein,51262,0.00525170768092464,0.00408868192804952,-0.00276210889805241,0.0132655242599017,0.198998015621252
CR2,Complement receptor type 2,Blood and urine assays,X30720.Cystatin C,51334,0.0796240379498342,0.00410697846296661,0.0715743601624196,0.0876737157372487,4.80596575570391e-83
CR2,Complement receptor type 2,Blood and urine assays,X30730.Gamma glutamyltransferase,51322,0.0183373369174102,0.0041058934536206,0.0102897857483139,0.0263848880865066,8.0051879631052e-06
CR2,Complement receptor type 2,Blood and urine assays,X30740.Glucose,49467,0.00780929135615068,0.00387012798238461,0.000223840510676849,0.0153947422016245,0.0436212825338103
CR2,Complement receptor type 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51265,0.0199455872637264,0.00394842547310257,0.0122066733364454,0.0276845011910074,4.41780048023255e-07
CR2,Complement receptor type 2,Blood and urine assays,X30760.HDL cholesterol,49473,-0.0915747736302602,0.00433472893260891,-0.100070842338174,-0.0830787049223467,5.23478091518633e-98
CR2,Complement receptor type 2,Blood and urine assays,X30770.IGF-1,51196,0.0188590646911821,0.00374631532536035,0.0115162866534759,0.0262018427288884,4.84062828519958e-07
CR2,Complement receptor type 2,Blood and urine assays,X30780.LDL direct,51276,-0.0110177551921644,0.00352316270721726,-0.0179231540983103,-0.00411235628601858,0.00176688417003687
CR2,Complement receptor type 2,Blood and urine assays,X30790.Lipoprotein A,46848,0.000171154114747346,0.00400817031099919,-0.00768485969481106,0.00802716792430575,0.965940119847257
CR2,Complement receptor type 2,Blood and urine assays,X30810.Phosphate,49444,0.00434551261277545,0.00403892776196142,-0.00357078580066893,0.0122618110262198,0.281981451979318
CR2,Complement receptor type 2,Blood and urine assays,X30830.SHBG,49307,-0.006892179650373,0.00468481010973266,-0.016074407465449,0.00229004816470301,0.14125920212122
CR2,Complement receptor type 2,Blood and urine assays,X30840.Total bilirubin,51235,0.0230507219110755,0.00394768779465769,0.0153132538335465,0.0307881899886046,5.32379932678368e-09
CR2,Complement receptor type 2,Blood and urine assays,X30850.Testosterone,48735,-0.0154113577951804,0.00621922718292553,-0.0276010430737144,-0.00322167251664633,0.0132198259818911
CR2,Complement receptor type 2,Blood and urine assays,X30860.Total protein,49466,0.029112322565771,0.00376325933629666,0.0217363342666296,0.0364883108649125,1.07430357675428e-14
CR2,Complement receptor type 2,Blood and urine assays,X30870.Triglycerides,51314,0.0338846710060017,0.00410224603350486,0.0258442687803321,0.0419250732316712,1.53722885403316e-16
CR2,Complement receptor type 2,Blood and urine assays,X30880.Urate,51293,0.0316744432196021,0.0044081462273213,0.0230344766140523,0.0403144098251518,6.91218567336581e-13
CR2,Complement receptor type 2,Blood and urine assays,X30890.Vitamin D,50199,-0.000736548802731288,0.00417301837618171,-0.00891566482004744,0.00744256721458486,0.859900768435872
CR2,Complement receptor type 2,Physical measures,X3137.Number of measurements made,49848,0.0153293847000309,0.0304908430384338,-0.0444326676552993,0.0750914370553611,0.615142797754836
CR2,Complement receptor type 2,Physical measures,X3143.Ankle spacing width,42359,0.0159303583847577,0.00621601940227452,0.00374696035629969,0.0281137564132158,0.0103944705978027
CR2,Complement receptor type 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42358,-0.00786084050741179,0.00484537469632966,-0.0173577749122179,0.00163609389739435,0.104754721769185
CR2,Complement receptor type 2,Physical measures,X3146.Speed of sound through heel,42359,-0.00574576256139364,0.00463655991507656,-0.0148334199949437,0.00334189487215642,0.21528255149247
CR2,Complement receptor type 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42359,-0.00684001636901942,0.00469479137178831,-0.0160418074577245,0.00236177471968568,0.145157555966774
CR2,Complement receptor type 2,Physical measures,X3148.Heel bone mineral density (BMD),42347,-0.00797714589001292,0.00470248895986692,-0.0171940242513521,0.00123973247132624,0.0898401103468034
CR2,Complement receptor type 2,Health and medical history,X3526.Mother's age at death,48459,-0.00207151622369913,0.00379772915294432,-0.00951506536347001,0.00537203291607174,0.58544225351532
CR2,Complement receptor type 2,Health and medical history,X3581.Age at menopause (last menstrual period),38532,0.00471757260112386,0.00518989207865445,-0.00545461587303886,0.0148897610752866,0.363377579763397
CR2,Complement receptor type 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32825,-0.00764790909282265,0.00812412790772499,-0.0235711997919636,0.00827538160631833,0.34657167590691
CR2,Complement receptor type 2,Physical measures,X4100.Ankle spacing width (left),36792,0.00562945454654712,0.00854309749592452,-0.011115016545465,0.0223739256385592,0.509949314724055
CR2,Complement receptor type 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36789,0.0025257479502323,0.00664835182714058,-0.0105050216309632,0.0155565175314278,0.704025905132716
CR2,Complement receptor type 2,Physical measures,X4103.Speed of sound through heel (left),36792,0.00148717351640817,0.00634798970293173,-0.010954886301338,0.0139292333341544,0.814778021900834
CR2,Complement receptor type 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36792,0.00172159088517221,0.00643403077633371,-0.0108891094364419,0.0143322912067863,0.789033129141733
CR2,Complement receptor type 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36788,0.00175185542658671,0.00642974314576345,-0.0108504411391097,0.0143541519922831,0.785274841507139
CR2,Complement receptor type 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36792,0.00172310654804953,0.00643401521163783,-0.0108875632667606,0.0143337763628597,0.788851295068708
CR2,Complement receptor type 2,Physical measures,X4119.Ankle spacing width (right),36792,0.00466384624016973,0.0084563621902807,-0.0119106236527804,0.0212383161331199,0.581294016770985
CR2,Complement receptor type 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36791,-0.00350943836810759,0.00662982216708033,-0.016503889815585,0.00948501307936986,0.596584210373832
CR2,Complement receptor type 2,Physical measures,X4122.Speed of sound through heel (right),36792,-0.0024234025251095,0.00633002680830391,-0.0148302550693852,0.00998345001916616,0.70184734616286
CR2,Complement receptor type 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36792,-0.00289765993819305,0.0064168253093212,-0.0154746375444626,0.0096793176680765,0.651590088070063
CR2,Complement receptor type 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36787,-0.00423492279148043,0.00641272359960492,-0.0168038610467061,0.00833401546374522,0.509021194421758
CR2,Complement receptor type 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36792,-0.00289798406908088,0.00641682102327874,-0.0154749532747072,0.00967898513654546,0.651553476235445
CR2,Complement receptor type 2,Physical measures,X4194.Pulse rate,37138,0.00114404181941485,0.00609127840411735,-0.0107948638526552,0.0130829474914849,0.851025396965896
CR2,Complement receptor type 2,Physical measures,X4195.Pulse wave reflection index,37138,-0.00499034693334961,0.00658342538882497,-0.0178938606954465,0.00791316682874733,0.448463421348177
CR2,Complement receptor type 2,Physical measures,X4196.Pulse wave peak to peak time,37133,-0.00326110137656766,0.00601464934701831,-0.0150498140967236,0.00852761134358824,0.587700705658553
CR2,Complement receptor type 2,Physical measures,X4198.Position of the pulse wave peak,37138,0.00917408733586293,0.00642371744142364,-0.00341639884932742,0.0217645735210533,0.153285524485326
CR2,Complement receptor type 2,Physical measures,X4199.Position of pulse wave notch,37138,0.00890349248637341,0.0061613225095063,-0.00317269963225893,0.0209796846050057,0.148479939443155
CR2,Complement receptor type 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,37138,0.00891529278691926,0.00632730174332393,-0.00348621862999565,0.0213168042038342,0.158868484492521
CR2,Complement receptor type 2,Physical measures,X4269.Number of triplets attempted (left),36954,0.134351645304298,0.11423219241521,-0.0895434518295125,0.358246742438109,0.239579996317285
CR2,Complement receptor type 2,Physical measures,X4270.Volume level set by participant (left),36863,0.0334303234013102,0.038962993770172,-0.0429371443882268,0.109797791190847,0.390918228009693
CR2,Complement receptor type 2,Physical measures,X4276.Number of triplets attempted (right),36948,0.0980381929294449,0.111613172305614,-0.120723624789559,0.316800010648449,0.379767641815257
CR2,Complement receptor type 2,Physical measures,X4277.Volume level set by participant (right),36854,0.0535607251066316,0.0382513993530794,-0.021412017625404,0.128533467838667,0.161485221567682
CR2,Complement receptor type 2,Cognitive function,X4288.Time to answer,37141,-0.00765704087708716,0.00721850702705325,-0.0218053146501115,0.0064912328959372,0.288835165291092
CR2,Complement receptor type 2,Cognitive function,X4290.Duration screen displayed,37141,0.00359685327767287,0.00680653148019084,-0.00974394842350117,0.0169376549788469,0.597207740080391
CR2,Complement receptor type 2,Physical measures,X46.Hand grip strength (left),52335,-0.0121375245908037,0.00517676114534046,-0.0222839764356711,-0.00199107274593643,0.0190550164844209
CR2,Complement receptor type 2,Physical measures,X47.Hand grip strength (right),52363,-0.0144076346919347,0.00514170366517714,-0.0244853738756818,-0.00432989550818745,0.00508112154132276
CR2,Complement receptor type 2,Physical measures,X48.Waist circumference,52426,0.018304475143006,0.00783051895094078,0.00295665799916209,0.0336522922868499,0.0194174199596303
CR2,Complement receptor type 2,Health and medical history,X4803.Tinnitus,37043,0.102600739702524,0.0432438840383605,0.0178427269873372,0.18735875241771,0.0176870173908974
CR2,Complement receptor type 2,Working and living environment,X4825.Noisy workplace,37124,-0.0445714355345781,0.0499743601379214,-0.142521181404904,0.0533783103357479,0.372481071285501
CR2,Complement receptor type 2,Working and living environment,X4836.Loud music exposure frequency,37081,-0.135883863610131,0.0819408675317026,-0.296487963972269,0.0247202367520056,0.0972934474107343
CR2,Complement receptor type 2,Physical measures,X49.Hip circumference,52421,0.00339373919064482,0.0063785514580975,-0.00910822166722628,0.0158957000485159,0.594693101158348
CR2,Complement receptor type 2,Physical measures,X50.Standing height,52400,0.021564316485986,0.00507484113597734,0.0116176278594704,0.0315110051125016,2.15314793526923e-05
CR2,Complement receptor type 2,Health and medical history,X5057.Number of older siblings,35895,-0.0121140766914076,0.0419879457049312,-0.0944104502730727,0.0701822968902576,0.772962850743447
CR2,Complement receptor type 2,Physical measures,X51.Seated height,52307,0.020963602133683,0.00473463718620358,0.011683713248724,0.030243491018642,9.56750174653319e-06
CR2,Complement receptor type 2,Eye measures,X5181.Ever had eye surgery,34524,0.0167204330029105,0.0859707191241122,-0.151782176480349,0.18522304248617,0.845799750848759
CR2,Complement receptor type 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34510,-0.00764427494331277,0.00735180382586614,-0.0220538104420104,0.00676526055538486,0.298488376889632
CR2,Complement receptor type 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34510,-0.000230203541968177,0.00753447354760561,-0.0149977716952752,0.0145373646113388,0.975626878777913
CR2,Complement receptor type 2,Eye measures,X5190.Duration at which refractometer first shown (right),34439,0.000653807489860564,0.00770683985211997,-0.0144515986202946,0.0157592136000157,0.932396039710176
CR2,Complement receptor type 2,Eye measures,X5193.Duration at which refractometer first shown (left),34438,-0.00128912751547759,0.00778226063498366,-0.0165423583600456,0.0139641033290904,0.868439182350006
CR2,Complement receptor type 2,Eye measures,"X5199.logMAR, initial (right)",34493,-0.0111275047213833,0.0497291368759099,-0.108596612998167,0.0863416035554001,0.82295091468839
CR2,Complement receptor type 2,Eye measures,X5200.Final number of letters displayed (right),34493,-0.621602519679098,0.280254094692693,-1.17090054527678,-0.0723044940814198,0.0265973510656644
CR2,Complement receptor type 2,Eye measures,"X5201.logMAR, final (right)",34435,-0.00778405308197723,0.00812371580774483,-0.0237065360651571,0.00813842990120264,0.338011788158598
CR2,Complement receptor type 2,Eye measures,X5202.Number of rounds to result (right),34493,0.00939816350694055,0.0459397972234069,-0.0806438390509369,0.099440166064818,0.837911560995662
CR2,Complement receptor type 2,Eye measures,"X5206.logMAR, initial (left)",34490,-0.0280327282706767,0.049925158801271,-0.125886039521168,0.0698205829798145,0.57448388417578
CR2,Complement receptor type 2,Eye measures,X5207.Final number of letters displayed (left),34490,-0.175482673858664,0.26639971709822,-0.697626119371175,0.346660771653848,0.510104590971393
CR2,Complement receptor type 2,Eye measures,"X5208.logMAR, final (left)",34430,-0.00458502037627837,0.00811117764702526,-0.0204829285644479,0.0113128878118911,0.571913093202922
CR2,Complement receptor type 2,Eye measures,X5209.Number of rounds to result (left),34488,-0.00992356099241154,0.0461592146971303,-0.100395621798787,0.0805484998139638,0.829786936285939
CR2,Complement receptor type 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34237,0.000341774440974832,0.00748971468253343,-0.0143380663367907,0.0150216152187404,0.963604967871604
CR2,Complement receptor type 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34237,-0.00255418629073649,0.00756518718303268,-0.0173819531694805,0.0122735805880076,0.735660851603981
CR2,Complement receptor type 2,Eye measures,X5256.Corneal hysteresis (right),34237,0.000708335404143879,0.00755281397398242,-0.0140951799848617,0.0155118507931494,0.925284225734645
CR2,Complement receptor type 2,Eye measures,X5257.Corneal resistance factor (right),34237,0.00076209985921265,0.0076257781281619,-0.0141844252719847,0.01570862499041,0.920398056852774
CR2,Complement receptor type 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34228,-0.0027490311061025,0.00746010810704035,-0.0173708429959016,0.0118727807836966,0.712517812355347
CR2,Complement receptor type 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34228,-0.00109931641806991,0.0075415797429011,-0.0158808127141561,0.0136821798780162,0.884110853787798
CR2,Complement receptor type 2,Eye measures,X5264.Corneal hysteresis (left),34228,0.00435226120034943,0.00763113812416534,-0.0106047695230146,0.0193092919237135,0.56847986678045
CR2,Complement receptor type 2,Eye measures,X5265.Corneal resistance factor (left),34228,0.00159381890909792,0.0076656737591719,-0.013430901658879,0.0166185394770748,0.835302693396337
CR2,Complement receptor type 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34632,0.0601986922386771,0.257846914385444,-0.445181259956793,0.565578644434148,0.815407741502109
CR2,Complement receptor type 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52364,0.01414774690421,0.0190612785912957,-0.0232123591347296,0.0515078529431496,0.457958884688459
CR2,Complement receptor type 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52364,0.0117840094205722,0.0202638549571222,-0.0279331462953872,0.0515011651365317,0.560889964984512
CR2,Complement receptor type 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52364,0.135239551037424,0.0545330928753563,0.0283546890017257,0.242124413073122,0.0131469918233851
CR2,Complement receptor type 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52364,0.00343417947853399,0.00824116800435104,-0.012718509809994,0.019586868767062,0.676894189855227
CR2,Complement receptor type 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52364,-0.00580017949074682,0.00775635550998696,-0.0210026362903213,0.00940227730882762,0.454590192803685
CR2,Complement receptor type 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38370,-0.011129059602887,0.0114739085603311,-0.033617920381136,0.011359801175362,0.332099500809595
CR2,Complement receptor type 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38370,0.0158495589840532,0.0245005860886536,-0.0321715897497079,0.0638707077178142,0.517709416908056
CR2,Complement receptor type 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38370,-0.0480969566712131,0.0304028324044228,-0.107686508183882,0.0114925948414556,0.113686469341161
CR2,Complement receptor type 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38370,-0.0276363478516028,0.0162891731878819,-0.0595631272998513,0.00429043159664571,0.0898046398000949
CR2,Complement receptor type 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52438,0.0061836878521524,0.0160877338844325,-0.0253482705613354,0.0377156462656402,0.700705649172251
CR2,Complement receptor type 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52438,0.0061836878521524,0.0160877338844325,-0.0253482705613354,0.0377156462656402,0.700705649172251
CR2,Complement receptor type 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52438,0.0255028315067921,0.012936966355027,0.000146377450939181,0.050859285562645,0.0486997373329197
CR2,Complement receptor type 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52438,0.00684971592148631,0.0224028604268746,-0.0370598905151879,0.0507593223581605,0.759796333388939
CR2,Complement receptor type 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52438,0.0861053275084575,0.0536351618878516,-0.0190195897917316,0.191230244808647,0.108421691133479
CR2,Complement receptor type 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52438,0.0419245489816913,0.0366710715495607,-0.0299507512554477,0.11379984921883,0.252942661416111
CR2,Complement receptor type 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52438,-0.081766776452957,0.0595643752909647,-0.198512952023248,0.0349793991173337,0.169844470548924
CR2,Complement receptor type 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52364,0.000251531847192428,0.0119101795006877,-0.0230924199741555,0.0235954836685404,0.983150858994966
CR2,Complement receptor type 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52364,0.0151977313479553,0.020088570727145,-0.024175867277249,0.0545713299731595,0.449335457403883
CR2,Complement receptor type 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52364,0.0139935478365516,0.0119178197160425,-0.00936537880689161,0.0373524744799948,0.240338958826452
CR2,Complement receptor type 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52364,0.000351562185028825,0.0168430056951186,-0.0326607289774035,0.0333638533474612,0.983347233243708
CR2,Complement receptor type 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52364,-0.0175659987313022,0.0203972781913639,-0.0575446639863755,0.022412666523771,0.389140517138266
CR2,Complement receptor type 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52364,0.0279149735385025,0.00797272100959751,0.0122884403596914,0.0435415067173136,0.000463846505136566
CR2,Complement receptor type 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38938,0.00601877418036084,0.0185620083453755,-0.0303627621765752,0.0424003105372969,0.745753977879421
CR2,Complement receptor type 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38938,-0.0481660688211273,0.0159042374095323,-0.0793383741438107,-0.0169937634984439,0.00246410021185785
CR2,Complement receptor type 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38938,0.045767202993627,0.022886295497266,0.000910063818985549,0.0906243421682684,0.0455534021416965
CR2,Complement receptor type 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38938,0.0523537237915589,0.0179797232519588,0.0171134662177197,0.0875939813653981,0.00360144294730041
CR2,Complement receptor type 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52358,-0.0589316111330231,0.0274838598610621,-0.112799976460705,-0.00506324580534137,0.0320251453380663
CR2,Complement receptor type 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52358,-0.0411674090618475,0.0418805936246971,-0.123253372566254,0.0409185544425587,0.325631977454003
CR2,Complement receptor type 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52358,-0.0282408628061849,0.0662009060526599,-0.157994638669398,0.101512913057028,0.669679544820296
CR2,Complement receptor type 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52358,-0.0418080254206858,0.0694439138468104,-0.177918096560434,0.0943020457190626,0.547153293837828
CR2,Complement receptor type 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52358,-0.00400665850804505,0.0225808630269074,-0.0482651500407835,0.0402518330246934,0.859167466181763
CR2,Complement receptor type 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52358,-0.0260130867941514,0.0310941365667906,-0.0869575944650609,0.034931420876758,0.402830919522755
CR2,Complement receptor type 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52358,0.0200075087748387,0.0165139487412366,-0.012359830757985,0.0523748483076624,0.22569625035258
CR2,Complement receptor type 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",36055,-0.00375691452242723,0.0224774470875404,-0.0478127108140063,0.0402988817691519,0.867263628199482
CR2,Complement receptor type 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",36055,-0.00362932197146188,0.0235129160313728,-0.0497146373929526,0.0424559934500289,0.87733484872458
CR2,Complement receptor type 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",36055,0.000965595847695157,0.0327775794249778,-0.0632784598252613,0.0652096515206516,0.976499347195249
CR2,Complement receptor type 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",36055,-0.0199718436262127,0.0137302055516049,-0.0468830465073583,0.00693935925493297,0.145828063524592
CR2,Complement receptor type 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40641,-0.00240240341922068,0.0107164008094443,-0.0234065490057315,0.0186017421672901,0.822621196290685
CR2,Complement receptor type 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40641,-0.00483358958349049,0.0126416904117159,-0.0296113027904536,0.0199441236234727,0.702206567646292
CR2,Complement receptor type 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40641,0.00255207883176033,0.0104834796674104,-0.017995541316364,0.0230996989798846,0.807670360036334
CR2,Complement receptor type 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40641,0.0642637591400546,0.0241790029381787,0.0168729133812244,0.111654604898885,0.00787540419814621
CR2,Complement receptor type 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40641,-0.0114118880499478,0.0134692770962341,-0.0378116711585667,0.0149878950586711,0.39687172248147
CR2,Complement receptor type 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40641,0.014624055076643,0.0193106032110202,-0.0232247272169566,0.0524728373702425,0.448881543167011
CR2,Complement receptor type 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52364,0.0264323309966167,0.0221593301498488,-0.016999956097087,0.0698646180903204,0.232947868868595
CR2,Complement receptor type 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52364,0.0101035113590135,0.0168036189175379,-0.0228315817193607,0.0430386044373877,0.547666073141728
CR2,Complement receptor type 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52364,0.00595226641342683,0.0420614592693493,-0.0764881937544979,0.0883927265813515,0.887465486826451
CR2,Complement receptor type 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52364,0.00718111316768292,0.0156738952010307,-0.0235397214263373,0.0379019477617032,0.646843563644863
CR2,Complement receptor type 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52364,0.0408118634370926,0.0184536797712531,0.00464265108543656,0.0769810757887486,0.027005142691983
CR2,Complement receptor type 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52364,-0.00126483038277421,0.022212534808845,-0.0448013986081103,0.0422717378425619,0.954591736871335
CR2,Complement receptor type 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52364,0.0166242612196065,0.00744501773589489,0.00203202645725252,0.0312164959819605,0.0255625615615031
CR2,Complement receptor type 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34951,0.00280167967089145,0.019151887573237,-0.0347360199726531,0.040339379314436,0.883699640090696
CR2,Complement receptor type 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34951,0.0295205435514199,0.0235958079962355,-0.0167272401212017,0.0757683272240415,0.210951481950811
CR2,Complement receptor type 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34951,0.0149710400661831,0.0164685026829949,-0.0173072251924868,0.0472493053248531,0.363350637732186
CR2,Complement receptor type 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34951,-0.00561300562527196,0.0154786496536972,-0.0359511589465184,0.0247251476959745,0.716895431570656
CR2,Complement receptor type 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52463,6.85145291453871e-05,0.009964260378171,-0.0194614358120698,0.0195984648703606,0.994513825933054
CR2,Complement receptor type 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52463,0.0185644436768389,0.0277483261915274,-0.0358222756585548,0.0729511630122325,0.503483415177837
CR2,Complement receptor type 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52463,0.0120606424507517,0.00829148527929047,-0.00419066869665762,0.028311953598161,0.145798598917597
CR2,Complement receptor type 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52463,0.00311643725135899,0.00797256931508853,-0.0125097986062145,0.0187426731089325,0.695878450142232
CR2,Complement receptor type 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52463,0.0217701351241969,0.0135865490393456,-0.00485950099292041,0.0483997712413143,0.109096228599491
CR2,Complement receptor type 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52463,0.00383437176304754,0.0101801097199202,-0.0161186432879961,0.0237873868140912,0.706434718131063
CR2,Complement receptor type 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52463,0.0119907241490884,0.0083397836897169,-0.00435525188275668,0.0283367001809335,0.150511636534544
CR2,Complement receptor type 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52463,-0.0144044694454716,0.0255459802041774,-0.0644745906456593,0.0356656517547161,0.572851836542416
CR2,Complement receptor type 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45756,-0.0211427169745738,0.00858958302350365,-0.037978299700641,-0.00430713424850669,0.013848290524183
CR2,Complement receptor type 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45756,-0.0377396089088141,0.0089232154158034,-0.0552291111237888,-0.0202501066938394,2.3560167590382e-05
CR2,Complement receptor type 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45756,0.0341881146568387,0.0094372234839833,0.0156911566282315,0.052685072685446,0.000292429304003381
CR2,Complement receptor type 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45756,-0.00567147450267032,0.0129032566473858,-0.0309618575315464,0.0196189085262058,0.66027732694646
CR2,Complement receptor type 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45756,0.015113880466723,0.00862232125394441,-0.001785869191008,0.0320136301244541,0.0796413869532731
CR2,Complement receptor type 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52230,0.00128935048281931,0.00872309679081265,-0.0158079192271735,0.0183866201928121,0.882494956614101
CR2,Complement receptor type 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52230,-0.00112611020321894,0.00708773476736468,-0.0150180703472537,0.0127658499408158,0.87376359899357
CR2,Complement receptor type 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52230,0.00801544282222552,0.00733270140727775,-0.00635665193603887,0.0223875375804899,0.274357320659027
CR2,Complement receptor type 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52230,-0.0757528332428,0.0159171665103601,-0.106950479603106,-0.0445551868824941,1.95549564977286e-06
CR2,Complement receptor type 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52249,-0.0101219553845829,0.00788227588356741,-0.025571216116375,0.00532730534720925,0.199105451025387
CR2,Complement receptor type 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52249,-0.0584082514860017,0.0156181775257431,-0.0890198794364582,-0.0277966235355451,0.000184640961437664
CR2,Complement receptor type 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52364,0.00549782213006339,0.00719475908243749,-0.00860390567151408,0.0195995499316409,0.444790031595938
CR2,Complement receptor type 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52364,-0.0170266082920797,0.0082469970403951,-0.0331907224912541,-0.000862494092905321,0.0389735934636871
CR2,Complement receptor type 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52364,0.000301541769797485,0.0125158524086164,-0.0242295289510907,0.0248326124906856,0.980778804039724
CR2,Complement receptor type 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52364,-0.023128876074915,0.0171544190121016,-0.0567515373386341,0.0104937851888041,0.177583096145732
CR2,Complement receptor type 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52364,0.0156599724058081,0.0217484179449842,-0.0269669267663608,0.0582868715779771,0.471500793070896
CR2,Complement receptor type 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52364,-0.00475848101172706,0.0206225801999316,-0.0451787382035931,0.035661776180139,0.817517821866564
CR2,Complement receptor type 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42359,-0.00683596506136486,0.00469476676686089,-0.0160377079244122,0.00236577780168249,0.145393818403432
CR2,Complement receptor type 2,Physical activities,X864.Number of days or week walked 10+ minutes,51870,-0.0177530909984399,0.0232511122654927,-0.0633252710388056,0.0278190890419257,0.445150984324605
CR2,Complement receptor type 2,Physical activities,X874.Duration of walks,48756,-0.00325650234808137,0.00393781340107128,-0.0109746166141811,0.00446161191801833,0.408257128479011
CR2,Complement receptor type 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50919,-0.041049374227828,0.0224789281366717,-0.0851080733757044,0.0030093249200485,0.0678448783449695
CR2,Complement receptor type 2,Physical activities,X894.Duration of moderate activity,46023,-0.0208538387905391,0.0275762227056215,-0.0749032352935573,0.033195557712479,0.44952467967482
CR2,Complement receptor type 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33505,-0.0113457371919184,0.00921310574407256,-0.0294034244503006,0.00671195006646381,0.218211306337401
CR2,Complement receptor type 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50819,-0.067571665469208,0.0232945573257578,-0.113228997827693,-0.0219143331107226,0.00372647092204888
CR2,Complement receptor type 2,Physical activities,X914.Duration of vigorous activity,40462,-0.00383959574932656,0.00481883571200395,-0.0132845137448543,0.00560532224620118,0.425590316782861
